<SEC-DOCUMENT>0001193125-23-298155.txt : 20231219
<SEC-HEADER>0001193125-23-298155.hdr.sgml : 20231219
<ACCEPTANCE-DATETIME>20231219074033
ACCESSION NUMBER:		0001193125-23-298155
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20231215
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231219
DATE AS OF CHANGE:		20231219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			XOMA Corp
		CENTRAL INDEX KEY:			0000791908
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				522154066
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39801
		FILM NUMBER:		231495642

	BUSINESS ADDRESS:	
		STREET 1:		2200 POWELL STREET
		STREET 2:		SUITE 310
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		510-204-7239

	MAIL ADDRESS:	
		STREET 1:		2200 POWELL STREET
		STREET 2:		SUITE 310
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XOMA LTD /DE/
		DATE OF NAME CHANGE:	19990107

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XOMA CORP /DE/
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d669381d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xoma="http://www.xoma.com/20231215" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2023-12-15_to_2023-12-15">XOMA Corp</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityIncorporationStateCountryCode" name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-12-15_to_2023-12-15">DE</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-12-15_to_2023-12-15">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-12-15_to_2023-12-15">0000791908</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="xoma-20231215.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-12-15_to_2023-12-15"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-12-15</xbrli:startDate> <xbrli:endDate>2023-12-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-12-15</xbrli:startDate> <xbrli:endDate>2023-12-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-12-15</xbrli:startDate> <xbrli:endDate>2023-12-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-12-15</xbrli:startDate> <xbrli:endDate>2023-12-15</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-12-15_to_2023-12-15">8-K</ix:nonNumeric></span></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event Reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-12-15_to_2023-12-15" format="ixt:datemonthdayyearen">December&#160;15, 2023</ix:nonNumeric></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">XOMA CORPORATION</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Charter)</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"> <span style=" -sec-ix-hidden:Hidden_dei_EntityIncorporationStateCountryCode">DELAWARE</span> </span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-12-15_to_2023-12-15">001-39801</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-12-15_to_2023-12-15">52-2154066</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification Number)</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-12-15_to_2023-12-15">2200 Powell Street</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2023-12-15_to_2023-12-15">Suite 310</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-12-15_to_2023-12-15">Emeryville</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-12-15_to_2023-12-15" format="ixt-sec:stateprovnameen">California</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-12-15_to_2023-12-15">94608</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices) (Zip Code)</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-12-15_to_2023-12-15">(510)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-12-15_to_2023-12-15">204-7200</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-12-15_to_2023-12-15" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-12-15_to_2023-12-15" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-12-15_to_2023-12-15" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-12-15_to_2023-12-15" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class:</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">symbol(s):</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br />on which registered:</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">Common Stock, $0.0075 par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">XOMA</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" format="ixt-sec:exchnameen">The Nasdaq Global Market</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember">8.625% Series A Cumulative Perpetual Preferred Stock, par value $0.05 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember">XOMAP</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember" format="ixt-sec:exchnameen">The Nasdaq Global Market</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember">Depositary Shares (each representing 1/1000th interest in a share of 8.375% Series B Cumulative Perpetual Preferred Stock, par value $0.05 per share)</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember">XOMAO</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember" format="ixt-sec:exchnameen">The Nasdaq Global Market</ix:nonNumeric></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (17 CFR <span style="white-space:nowrap">&#167;240.12b-2).</span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-12-15_to_2023-12-15" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;1.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&#160;15, 2023, XOMA Corporation (&#8220;<span style="text-decoration:underline">XOMA</span>&#8221;), through XRL 1 LLC, a newly formed, wholly-owned subsidiary (the &#8220;<span style="text-decoration:underline">Subsidiary</span>&#8221;), entered into a <span style="white-space:nowrap">non-dilutive,</span> <span style="white-space:nowrap">non-recourse,</span> royalty-backed loan for up to $140&#160;million of capital (the &#8220;<span style="text-decoration:underline">Royalty Financing</span>&#8221;) with certain funds managed by the credit platform of Blue Owl Capital Inc. (collectively, &#8220;<span style="text-decoration:underline">Blue Owl</span>&#8221;). Pursuant to the Royalty Financing, XOMA, through another wholly-owned subsidiary, XOMA (US) LLC (&#8220;<span style="text-decoration:underline">XOMA US</span>&#8221;), contributed to the Subsidiary the following assets and rights related to VABYSMO<sup style="font-size:75%; vertical-align:top">&#174;</sup>: (i)&#160;XOMA US&#8217; Assignment Agreement, dated October&#160;6, 2021, with Affitech, F. <span style="white-space:nowrap">Hoffmann-La</span> Roche Ltd and <span style="white-space:nowrap">Hoffman-La</span> Roche Inc; (ii)&#160;certain commercial payments under XOMA US&#8217; Commercial Payment Purchase Agreement (the &#8220;<span style="text-decoration:underline">CPPA</span>&#8221;), dated October&#160;6, 2021, with Affitech Research AS (&#8220;<span style="text-decoration:underline">Affitech</span>&#8221;); (iii) any rights to erroneous payments in respect of such payments under the CPPA; and (iv)&#160;all proceeds of the foregoing. The VABYSMO-related assets and rights contributed to the Subsidiary are referred to herein as the &#8220;<span style="text-decoration:underline">Contributed Assets</span>.&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Simultaneously with the contribution and assignment of the Contributed Assets, the Subsidiary entered into a Loan Agreement (the &#8220;<span style="text-decoration:underline">Loan Agreement</span>&#8221;), dated December&#160;15, 2023, with the lenders from time to time party thereto (the &#8220;<span style="text-decoration:underline">Lenders</span>&#8221;) and Blue Owl Capital Corporation, as administrative agent (the &#8220;<span style="text-decoration:underline">Administrative Agent</span>&#8221;), pursuant to which the lenders extended certain senior secured credit facilities to the Subsidiary (the &#8220;<span style="text-decoration:underline">Loan</span>&#8221;) in an aggregate principal amount of up to $140&#160;million (the &#8220;<span style="text-decoration:underline">Loan Amount</span>&#8221;). The principal and interest of the Loan is to be paid from royalties received on worldwide net sales of VABYSMO (the &#8220;<span style="text-decoration:underline">Commercial Payments</span>&#8221;). The Subsidiary is obligated to make semi-annual interest payments at a fixed rate of 9.875% per annum until the royalty-backed loan is repaid, at which time the Commercial Payments would revert back to XOMA. The Loan matures on December&#160;15, 2038, provided the Subsidiary may repay it in full at any time prior to December&#160;15, 2038, subject to the terms of the Loan Agreement. The Loan includes (i)&#160;an initial term loan in an aggregate principal amount equal to $130&#160;million and (ii)&#160;a delayed draw term loan in an aggregate principal amount of $10&#160;million to be funded at the option of the Subsidiary upon receipt by the Lenders of payments of principal and interest from the proceeds of commercial payments related to VABYSMO in excess of an agreed upon amount on or prior to March&#160;15, 2026. In exchange for the Contributed Assets, the Subsidiary will pay XOMA US up to $140&#160;million, less certain lender expenses. The Subsidiary paid Blue Owl a market rate of original issue discount and during the term of the Loan, XOMA will also pay Blue Owl an administrative fee at a market rate. The royalty payment obligations under the Loan Agreement are limited to the Subsidiary, and Blue Owl has no recourse under the Loan Agreement against XOMA or XOMA US or any assets other than the Contributed Assets and XOMA US&#8217; equity interest in the Subsidiary. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with entering into the Loan Agreement, (i)&#160;the Subsidiary granted Blue Owl a first-priority perfected lien on, and security interest in, (a)&#160;the Commercial Payments and the proceeds thereof, in each case under the CPPA and (b)&#160;all other assets of the Subsidiary and (ii)&#160;XOMA US granted Blue Owl a first-priority perfected lien on, and security interest in 100% of the equity of the Subsidiary. XOMA also issued to Blue Owl warrants (the &#8220;<span style="text-decoration:underline">Warrants</span>&#8221;), to purchase (i)&#160;up to 40,000 shares of XOMA&#8217;s common stock, par value $0.0075 (&#8220;<span style="text-decoration:underline">Common Stock</span>&#8221;) at an exercise price of $35.00 per share, the form of which is attached to this Current Report on Form <span style="white-space:nowrap">8-K</span> as Exhibit 4.1; (ii) up to 40,000 shares of Common Stock at an exercise price of $42.50 per share, the form of which is attached to this Current Report on Form <span style="white-space:nowrap">8-K</span> as Exhibit 4.2; and (iii)&#160;up to 40,000 shares of Common Stock at an exercise price of $50.00 per share, the form of which is attached to this Current Report on Form <span style="white-space:nowrap">8-K</span> as Exhibit 4.3. In the event of certain breaches of the Loan Agreement, the Administrative Agent may terminate the Loan Agreement and demand immediate payment of an amount equal to the Loan Amount plus Accreted Principal (as defined in the Loan Agreement), all interest thereon and all other obligations arising under or pursuant to the Loan Agreement and all other documents delivered in connection with such agreement. In the event that the Subsidiary fails to timely pay such amounts if and when due, then the Administrative Agent would have the right to foreclose on the pledged collateral. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Loan Agreement contains other customary terms and conditions, including representations and warranties, as well as indemnification obligations in favor of Blue Owl. The above description of the Loan Agreement is a summary of the material terms and does not purport to be complete; the summary is qualified in its entirety by reference to the Loan Agreement, a copy of which will be filed as an exhibit to XOMA&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> to be filed with the Securities and Exchange Commission for the fiscal year ending December&#160;31, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The above descriptions of the Warrants are summaries of the material terms and do not purport to be complete; the summaries are qualified in its entirety by reference to the respective forms of Warrant attached to this Current Report on Form <span style="white-space:nowrap">8-K</span> as Exhibits 4.1, 4.2 and 4.3 and incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;2.03</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Creation of a Direct Financial Obligation or an Obligation under an <span style="white-space:nowrap">Off-Balance</span> Sheet Arrangement of a Registrant. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information in Item 1.01 above relating to the Subsidiary&#8217;s obligations to make payments with respect to the Loan is incorporated by reference into this Item 2.03. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;3.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Unregistered Sales of Equity Securities. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information in Item 1.01 above relating to the issuance of the Warrant is incorporated by reference into this Item 3.02. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Warrants described in Item 1.01 above were offered and sold in reliance upon the exemption from registration provided by Section&#160;4(a)(2) under the Securities Act of 1933, as amended. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d)&#160;Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">&#160;&#160;&#160;&#160;No.&#160;&#160;&#160;&#160;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d669381dex41.htm">Form of Warrant (December 2023) ($35.00 Exercise Price) </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;4.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d669381dex42.htm">Form of Warrant (December 2023) ($42.50 Exercise Price) </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;4.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d669381dex43.htm">Form of Warrant (December 2023) ($50.00 Exercise Price) </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d669381dex991.htm">Press release, dated December&#160;19, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">XOMA CORPORATION</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: December&#160;19, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ THOMAS BURNS</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Thomas Burns</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Senior Vice President, Finance and Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>d669381dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#147;<B><U>ACT</U></B>&#148;), OR
THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND
SUBSTANCE SATISFACTORY TO THE ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WARRANT TO PURCHASE
STOCK </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Warrant No.:</B> [&#9679;] </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Company:</B>
XOMA Corporation, a Delaware corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Number of Shares:</B> [&#9679;], subject to adjustment </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Type/Series of Stock:</B> Common Stock, $0.0075 par value per share </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Warrant Price:</B> $35.00 per share, subject to adjustment </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Issue Date:</B> December&nbsp;15, 2023 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Expiration
Date:</B> December&nbsp;15, 2033 <B>See also Section</B><B></B><B>&nbsp;5.1(b).</B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Credit Facility:</B> This Warrant to Purchase Stock
(&#147;<B><U>Warrant</U></B>&#148;) is issued in connection with that certain Loan Agreement, of even date herewith, among XRL 1 LLC, as borrower, the lenders from time to time party thereto and Blue Owl Capital Corporation, as administrative agent
(as may be further amended and/or modified and in effect from time to time, the &#147;<B><U>Loan Agreement</U></B>&#148;; capitalized terms used herein but not defined herein shall have the meaning set forth in the Loan Agreement). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS WARRANT CERTIFIES THAT, for good and valuable consideration, [BLUE OWL CAPITAL CORPORATION] (together with any successor or permitted
assignee or transferee of this Warrant or of any shares issued upon exercise hereof, &#147;<B><U>Holder</U></B>&#148;) is entitled to purchase up to such number of fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> shares (the
&#147;<B><U>Shares</U></B>&#148;) of the above-stated Type/Series of Stock (the &#147;<B><U>Class</U></B>&#148;) of the above-named company (the &#147;<B><U>Company</U></B>&#148;), at the above-stated Warrant Price, all as set forth above and
subject to the provisions and upon the terms and conditions set forth in this Warrant. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SECTION 1. <U>EXERCISE</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1&nbsp;&nbsp;&nbsp;&nbsp;<U>Method of Exercise</U>. Holder may at any time and from time to time exercise this Warrant, in whole or in part,
by delivering to the Company the original of this Warrant together with a duly executed Notice of Exercise in substantially the form attached hereto as Appendix 1 and, unless Holder is exercising this Warrant pursuant to a cashless exercise set
forth in Section&nbsp;1.2, a check, wire transfer of <FONT STYLE="white-space:nowrap">same-day</FONT> funds (to an account designated by the Company), or other form of payment acceptable to the Company for the aggregate Warrant Price for the Shares
being purchased. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2&nbsp;&nbsp;&nbsp;&nbsp;<U>Cashless Exercise</U>. On any exercise of this Warrant, in lieu of payment of the
aggregate Warrant Price in the manner as specified in Section&nbsp;1.1 above, but otherwise in accordance with the requirements of Section&nbsp;1.1, Holder may elect to receive Shares equal to the value of this Warrant, or portion hereof as to which
this Warrant is being exercised. Thereupon, the Company shall issue to the Holder such number of fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> Shares as are computed using the following formula: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">X = <FONT STYLE="white-space:nowrap">Y(A-B)/A</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">where: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">X = the
number of Shares to be issued to the Holder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Y = the number of Shares with respect to which this Warrant is being
exercised (inclusive of the Shares surrendered to the Company in payment of the aggregate Warrant Price); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">A = the Fair
Market Value (as determined pursuant to Section&nbsp;1.3 below) of one Share; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">B = the Warrant Price. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.3&nbsp;&nbsp;&nbsp;&nbsp;<U>Fair Market Value</U>. If shares of the Class&nbsp;are then
traded or quoted on a nationally recognized securities exchange, inter-dealer quotation system or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market (a &#147;<B><U>Trading Market</U></B>&#148;),
the fair market value of a Share shall be the closing price or last sale price of a share of the Class&nbsp;reported for the Business Day immediately before the date on which Holder delivers this Warrant together with its Notice of Exercise to the
Company. If shares of the Class&nbsp;are not then traded in a Trading Market, the Board of Directors of the Company shall determine the fair market value of a Share in its reasonable good faith judgment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.4&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery of Certificate and New Warrant</U>. Within a reasonable time after Holder exercises this Warrant in the
manner set forth in Section&nbsp;1.1 or 1.2 above, the Company shall deliver to Holder a certificate representing the Shares issued to Holder upon such exercise (which certificate may be in the form of an electronic certificate or DTC entry, to the
extent used by the Company at the time of such exercise) and, if this Warrant has not been fully exercised and has not expired, a new warrant of like tenor representing the Shares not so acquired. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.5&nbsp;&nbsp;&nbsp;&nbsp;<U>Replacement of Warrant</U>. On receipt of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form, substance and amount to the Company or, in the case of mutilation, on surrender of this
Warrant to the Company for cancellation, the Company shall, within a reasonable time, execute and deliver to Holder, in lieu of this Warrant, a new warrant of like tenor and amount. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.6&nbsp;&nbsp;&nbsp;&nbsp;<U>Treatment of Warrant Upon Acquisition of Company</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Acquisition</U>. For the purpose of this Warrant, &#147;<B><U>Acquisition</U></B>&#148; means any
transaction or series of related transactions involving: (i)&nbsp;the sale, lease, exclusive license, or other disposition of all or substantially all of the assets of the Company; (ii)&nbsp;any merger or consolidation of the Company into or with
another person or entity (other than a merger or consolidation effected exclusively to change the Company&#146;s domicile), or any other corporate reorganization, in which the stockholders of the Company in their capacity as such immediately prior
to such merger, consolidation or reorganization, own less than a majority of the Company&#146;s (or the surviving or successor entity&#146;s) outstanding voting power immediately after such merger, consolidation or reorganization (or, if such
Company stockholders beneficially own a majority of the outstanding voting power of the surviving or successor entity as of immediately after such merger, consolidation or reorganization, such surviving or successor entity is not the Company); or
(iii)&nbsp;any sale or other transfer by the stockholders of the Company of shares representing at least a majority of the Company&#146;s then-total outstanding combined voting power. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Treatment of Warrant at Acquisition</U>. In the event of an Acquisition in which the
consideration to be received by the Company&#146;s stockholders consists solely of cash, solely of Marketable Securities or a combination of cash and Marketable Securities (a &#147;<B><U>Cash/Public Acquisition</U></B>&#148;), and the fair market
value of one Share as determined in accordance with Section&nbsp;1.3 above would be greater than the Warrant Price in effect on such date immediately prior to such Cash/Public Acquisition, and Holder has not exercised this Warrant pursuant to
Section&nbsp;1.1 above as to all Shares, then this Warrant shall automatically be deemed to be Cashless Exercised pursuant to Section&nbsp;1.2 above as to all Shares effective immediately prior to and contingent upon the consummation of a
Cash/Public Acquisition. In connection with such Cashless Exercise, Holder shall be deemed to have restated each of the representations and warranties in Section&nbsp;4 of the Warrant as of the date thereof and the Company shall promptly notify the
Holder of the number of Shares (or such other securities) issued upon exercise. In the event of a Cash/Public Acquisition where the fair market value of one Share as determined in accordance with Section&nbsp;1.3 above would be less than the Warrant
Price in effect immediately prior to such Cash/Public Acquisition, then this Warrant will expire immediately prior to the consummation of such Cash/Public Acquisition. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Upon the closing of any Acquisition other than a Cash/Public Acquisition, the acquiring, surviving
or successor entity shall assume the obligations of this Warrant, and this Warrant shall thereafter be exercisable for the same securities and/or other property as would have been paid for the Shares issuable upon exercise of the unexercised portion
of this Warrant as if such Shares were outstanding on and as of the closing of such Acquisition, subject to further adjustment from time to time in accordance with the provisions of this Warrant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;As used in this Warrant, &#147;<B><U>Marketable
Securities</U></B>&#148; means securities meeting all of the following requirements: (i)&nbsp;the issuer thereof is then subject to the reporting requirements of Section&nbsp;13 or Section&nbsp;15(d) of the Securities Exchange Act of 1934, as
amended (the &#147;<B><U>Exchange Act</U></B>&#148;), and is then current in its filing of all required reports and other information under the Act and the Exchange Act; (ii)&nbsp;the class and series of shares or other security of the issuer that
would be received by Holder in connection with the Acquisition were Holder to exercise this Warrant on or prior to the closing thereof is then traded in a Trading Market, and (iii)&nbsp;following the closing of such Acquisition, Holder would not be
restricted from publicly <FONT STYLE="white-space:nowrap">re-selling</FONT> all of the issuer&#146;s shares and/or other securities that would be received by Holder in such Acquisition were Holder to exercise this Warrant in full on or prior to the
closing of such Acquisition, except to the extent that any such restriction (x)&nbsp;arises solely under federal or state securities laws, rules or regulations, and (y)&nbsp;does not extend beyond six (6)&nbsp;months from the closing of such
Acquisition. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SECTION 2. <U>ADJUSTMENTS TO THE SHARES</U> <U>AND WARRANT PRICE</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock Dividends, Splits, Etc</U>. If the Company declares or pays a dividend or distribution on the outstanding
shares of the Class&nbsp;payable in additional shares of the Class&nbsp;or other securities or property (other than cash), then upon exercise of this Warrant, for each Share acquired, Holder shall receive, without additional cost to Holder, the
total number and kind of securities and property which Holder would have received had Holder owned the Shares of record as of the date the dividend or distribution occurred. If the Company subdivides the outstanding shares of the Class&nbsp;by
reclassification or otherwise into a greater number of shares, the number of Shares purchasable hereunder shall be proportionately increased and the Warrant Price shall be proportionately decreased. If the outstanding shares of the Class&nbsp;are
combined or consolidated, by reclassification or otherwise, into a lesser number of shares, the Warrant Price shall be proportionately increased and the number of Shares shall be proportionately decreased. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2&nbsp;&nbsp;&nbsp;&nbsp;<U>Reclassification, Exchange, Combinations or Substitution</U>. Upon any event whereby all of the outstanding
shares of the Class&nbsp;are reclassified, exchanged, combined, substituted, or replaced for, into, with or by Company securities of a different class and/or series, then from and after the consummation of such event, this Warrant will be
exercisable for the number, class and series of Company securities that Holder would have received had the Shares been outstanding on and as of the consummation of such event, and subject to further adjustment thereafter from time to time in
accordance with the provisions of this Warrant. The provisions of this Section&nbsp;2.2 shall similarly apply to successive reclassifications, exchanges, combinations, substitutions, replacements or other similar events. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3&nbsp;&nbsp;&nbsp;&nbsp;<U>No </U><U>Fractional </U><U>Share</U>. No fractional Share shall be issuable upon exercise of this Warrant and
the number of Shares to be issued shall be rounded down to the nearest whole Share. If a fractional Share interest arises upon any exercise of the Warrant, the Company shall eliminate such fractional Share interest by paying Holder in cash the
amount computed by multiplying the fractional interest by (i)&nbsp;the fair market value (as determined in accordance with Section&nbsp;1.3 above) of a full Share, less (ii)&nbsp;the then-effective Warrant Price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice/Certificate as to Adjustments</U>. Upon each adjustment of the Warrant Price, Class&nbsp;and/or number of
Shares, the Company, at the Company&#146;s expense, shall notify Holder in writing within a reasonable time setting forth the adjustments to the Warrant Price, Class&nbsp;and/or number of Shares and facts upon which such adjustment is based. The
Company shall, upon written request from Holder, furnish Holder with a certificate of its Chief Financial Officer, including computations of such adjustment and the Warrant Price, Class&nbsp;and number of Shares in effect upon the date of such
adjustment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Treatment as to Adjustments</U>. The Company acknowledges its obligations to file and/or
publicly post (as applicable) an IRS Form 8937 (or similar tax form) if an adjustment (or lack thereof) to the Warrant entitlement results in a distribution under Section&nbsp;305(c) of the Internal Revenue Code of 1986, as amended, and agrees to
notify Holder on a timely basis in the event of such an adjustment (or lack thereof) and, in the case of any required IRS Form 8937 filing, consider, in good faith, any timely received, reasonable written comments of Holder in preparing such IRS
Form 8937. For the avoidance of doubt, if there is more than one permissible method to determine the amount of the constructive dividend for tax purposes, unless Holder gives notice otherwise, the Company agrees to select the method that results in
the lowest constructive dividend amount as long as such method is at a &#147;more likely than not&#148; level of comfort. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SECTION 3. <U>REPRESENTATIONS AND COVENANTS OF THE COMPANY</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations and Warranties</U>. The Company represents and warrants to, and agrees with, the Holder as
follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;All Shares which may be issued upon the exercise of this Warrant shall, upon issuance,
be duly authorized, validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable,</FONT> and free of any liens and encumbrances except for restrictions on transfer provided for herein or under applicable federal and state
securities laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company covenants that it shall at all times cause to be reserved and kept
available out of its authorized and unissued capital stock such number of shares of the Class&nbsp;and other securities as will be sufficient to permit the exercise in full of this Warrant. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;As of the date hereof, each representation and warranty set forth on Schedule 1 hereto is true and
correct. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice of Certain Events</U>. If the Company proposes at any time to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;declare any dividend or distribution upon the outstanding shares of the Class, whether in cash,
property, stock, or other securities and whether or not a regular cash dividend; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;offer for
subscription or sale pro rata to the holders of the outstanding shares of the Class&nbsp;any additional shares of any class or series of the Company&#146;s stock (other than pursuant to contractual <FONT STYLE="white-space:nowrap">pre-emptive</FONT>
rights); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;effect any reclassification, exchange, combination, substitution, reorganization or
recapitalization of the outstanding shares of the Class; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;effect an Acquisition or to
liquidate, dissolve or wind up; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">then, in connection with each such event, the Company shall give Holder notice thereof at the same time
and in the same manner as given to holders of the outstanding shares of the Class. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3&nbsp;&nbsp;&nbsp;&nbsp;<U>Direction to Transfer
Agent</U>. Upon each exercise of the Warrant (in whole or in part), the Company shall promptly deliver irrevocable authorization and direction to its transfer agent to issue book-entry statements representing the Shares. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SECTION 4. <U>REPRESENTATIONS AND WARRANTIES OF THE HOLDER.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Holder represents and warrants to the Company as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase for Own Account</U>. This Warrant and the Shares to be acquired upon exercise of this Warrant by Holder
are being acquired for investment for Holder&#146;s account, not as a nominee or agent, and not with a view to the public resale or distribution within the meaning of the Act. Holder also represents that it has not been formed for the specific
purpose of acquiring this Warrant or the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2&nbsp;&nbsp;&nbsp;&nbsp;<U>Disclosure of Information</U>. Holder is aware of the
Company&#146;s business affairs and financial condition and has received or has had full access to all the information it considers necessary or appropriate to make an informed investment decision with respect to the acquisition of this Warrant and
its underlying securities. Holder further has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the offering of this Warrant and its underlying securities and to obtain additional
information (to the extent the Company possessed such information or could acquire it without unreasonable effort or expense) necessary to verify any information furnished to Holder or to which Holder has access. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3&nbsp;&nbsp;&nbsp;&nbsp;<U>Investment Experience</U>. Holder understands that the
purchase of this Warrant and its underlying securities involves substantial risk. Holder has experience as an investor in securities of companies in the development stage and acknowledges that Holder can bear the economic risk of such Holder&#146;s
investment in this Warrant and its underlying securities and has such knowledge and experience in financial or business matters that Holder is capable of evaluating the merits and risks of its investment in this Warrant and its underlying securities
and/or has a preexisting personal or business relationship with the Company and certain of its officers, directors or controlling persons of a nature and duration that enables Holder to be aware of the character, business acumen and financial
circumstances of such persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.4&nbsp;&nbsp;&nbsp;&nbsp;<U>Accredited Investor Status</U>. Holder is an &#147;accredited investor&#148;
within the meaning of Regulation D promulgated under the Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.5&nbsp;&nbsp;&nbsp;&nbsp;<U>The Act</U>. Holder understands that this
Warrant and the Shares issuable upon exercise hereof have not been registered under the Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of the Holder&#146;s investment
intent as expressed herein. Holder understands that this Warrant and the Shares issued upon any exercise hereof must be held indefinitely unless subsequently registered under the Act and qualified under applicable state securities laws, or unless
exemption from such registration and qualification are otherwise available. Holder is aware of the provisions of Rule 144 promulgated under the Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.6&nbsp;&nbsp;&nbsp;&nbsp;<U>No Shareholder Rights</U>. Without limiting any provision of this Warrant, Holder agrees that as a Holder of
this Warrant it will not have any rights (including, but not limited to, voting rights) as a shareholder of the Company with respect to the Shares issuable hereunder unless and until the exercise of this Warrant and then only with respect to the
Shares issued on such exercise. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SECTION 5. <U>MISCELLANEOUS</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1&nbsp;&nbsp;&nbsp;&nbsp;<U>Term; Automatic Cashless Exercise Upon Expiration</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Term</U>. Subject to the provisions of Section&nbsp;1.6 above, this Warrant is exercisable in
whole or in part at any time and from time to time on or before 6:00 PM, Pacific time, on the Expiration Date and shall be void thereafter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Automatic Cashless Exercise upon Expiration</U>. In the event that, upon the Expiration Date, the
fair market value of one Share as determined in accordance with Section&nbsp;1.3 above is greater than the Warrant Price in effect on such date, then this Warrant shall automatically be deemed on and as of such date to be exercised pursuant to
Section&nbsp;1.2 above as to all Shares for which it shall not previously have been exercised, and the Company shall, within a reasonable time, deliver a certificate representing the Shares issued upon such exercise to Holder (which certificate may
be in the form of an electronic certificate or DTC entry, to the extent used by the Company at the time of such exercise). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2&nbsp;&nbsp;&nbsp;&nbsp;<U>Legends</U>. Each certificate evidencing Shares shall be imprinted with a legend in substantially the following
form: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">THE SHARES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
&#147;<B><U>ACT</U></B>&#148;), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN THAT CERTAIN WARRANT TO PURCHASE STOCK ISSUED BY THE ISSUER TO [BLUE OWL CAPITAL CORPORATION] DATED DECEMBER&nbsp;15, 2023, MAY NOT BE OFFERED, SOLD,
PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance with Securities Laws on Transfer</U>. This Warrant and the Shares issued upon exercise of this
Warrant may not be transferred or assigned in whole or in part except in compliance with applicable federal and state securities laws by the transferor and the transferee (including, without limitation, the delivery of investment representation
letters and legal opinions reasonably satisfactory to the Company, as reasonably requested by the Company). The Company shall not require Holder to provide an opinion of counsel if the transfer is to an affiliate of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Holder, provided that any such transferee is an &#147;accredited investor&#148; as defined in Regulation D promulgated under the Act. Additionally, the Company shall also not require an opinion
of counsel if there is no material question as to the availability of Rule 144 promulgated under the Act. For purposes of an affiliate transfer contemplated herein, the Company hereby approves each and every registered investment company, private
equity fund, venture capital fund, private or similar collective investment vehicle now or hereafter existing that is controlled by one or more affiliated general partners, managing members or investment advisers of, or shares an affiliated
management company or investment adviser with, the Holder as an &#147;affiliate&#148; of the Holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfer Procedure</U>. Subject to the provisions of Section&nbsp;5.3 and upon providing the Company with
written notice, [Blue Owl Capital Corporation] and any subsequent Holder may transfer all or part of this Warrant to any transferee, provided, however, in connection with any such transfer, [Blue Owl Capital Corporation] or any subsequent Holder
will give the Company notice of the portion of the Warrant being transferred with the name, address and taxpayer identification number of the transferee and Holder will surrender this Warrant to the Company for reissuance to the transferee(s) (and
Holder if applicable); and provided further, that any subsequent transferee of this Warrant or of any portion hereof shall agree in writing with the Company to be bound by all of the terms and conditions of this Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.5&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>. All notices and other communications hereunder from the Company to the Holder, or vice versa, shall
be deemed delivered and effective (i)&nbsp;when given personally, (ii)&nbsp;on the third (3rd) Business Day after being mailed by first-class registered or certified mail, postage prepaid, (iii)&nbsp;upon actual receipt if given by electronic mail
and such receipt is confirmed in writing by the recipient, or (iv)&nbsp;on the first Business Day following delivery to a reliable overnight courier service, courier fee prepaid, in any case at such address as may have been furnished to the Company
or Holder, as the case may be, in writing by the Company or such Holder from time to time in accordance with the provisions of this Section&nbsp;5.5. All notices to Holder shall be addressed as follows until the Company receives notice of a change
of address in connection with a transfer or otherwise: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">[Holder] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">c/o Blue Owl Capital Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">399 Park Avenue, 37th Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">New
York, NY 10022 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Telephone: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Email address: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">with a copy
(which shall not constitute notice) to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Cooley LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attn: Michael Tollini </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">1299
Pennsylvania Avenue, NW, Suite 700 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Washington, DC 20004-2400 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Email: &nbsp;&nbsp;&nbsp;&nbsp;mtollini@cooley.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Notice to the Company shall be addressed as follows until Holder receives notice of a change in address: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">XOMA Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attn: Chief
Financial Officer </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">2200 Powell Street, Suite 310 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Emeryville, CA 94608 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Telephone:
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Email: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">With a copy (which
shall not constitute notice) to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Gibson, Dunn&nbsp;&amp; Crutcher LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attn: Ryan Murr and Branden Berns </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">555 Mission Street, Suite #3000 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">San Francisco, CA 94105 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Telephone: (415) <FONT STYLE="white-space:nowrap">393-8373;</FONT> (415) <FONT STYLE="white-space:nowrap">393-4631</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Email: <U>rmurr@gibsondunn.com</U>; <U>bberns@gibsondunn.com</U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.6&nbsp;&nbsp;&nbsp;&nbsp;<U>Waiver</U>. This Warrant and any term hereof may be changed,
waived, discharged or terminated (either generally or in a particular instance and either retroactively or prospectively) only by an instrument in writing signed by the party against which enforcement of such change, waiver, discharge or termination
is sought. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.7&nbsp;&nbsp;&nbsp;&nbsp;<U>Attorneys</U><U>&#146;</U><U> Fees</U>. In the event of any dispute between the parties
concerning the terms and provisions of this Warrant, the party prevailing in such dispute shall be entitled to collect from the other party all costs incurred in such dispute, including reasonable attorneys&#146; fees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.8&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts</U><U>; Facsimile/Electronic Signatures</U>. This Warrant may be executed in counterparts, all of
which together shall constitute one and the same agreement. Any signature page delivered electronically or by facsimile shall be binding to the same extent as an original signature page with regards to any agreement subject to the terms hereof or
any amendment thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.9&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing Law</U>. This Warrant shall be governed by and construed in accordance
with the laws of the State of New York, without giving effect to its principles regarding conflicts of law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.10&nbsp;&nbsp;&nbsp;&nbsp;<U>Headings</U>. The headings in this Warrant are for purposes of reference only and shall not limit or otherwise
affect the meaning of any provision of this Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.11&nbsp;&nbsp;&nbsp;&nbsp;<U>Business Days</U>. &#147;<B><U>Business
Day</U></B>&#148; is any day that is not a Saturday, Sunday or other day on which commercial banks in New York City are authorized or required by Applicable Law to remain closed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Remainder of page left blank intentionally] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature page follows] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties have caused this Warrant to Purchase Stock to be executed by
their duly authorized representatives effective as of the Issue Date written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#147;COMPANY&#148;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>XOMA CORPORATION</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Thomas Burns</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#147;HOLDER&#148;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>[BLUE OWL CAPITAL CORPORATION]</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">APPENDIX 1 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>NOTICE OF EXERCISE </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;The undersigned Holder hereby exercises its right to purchase ___________ shares of the Common/Series ______
Preferred [circle one] Stock of __________________ (the &#147;<B><U>Company</U></B>&#148;) in accordance with the attached Warrant To Purchase Stock, and tenders payment of the aggregate Warrant Price for such shares as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[ ]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;check in the amount of $________ payable to
order of the Company enclosed herewith </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[
]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Wire transfer of immediately available funds to the Company&#146;s account </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[ ]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cashless Exercise pursuant to
Section&nbsp;1.2 of the Warrant </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[ ]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
[Describe] __________________________________________ </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;Please issue a certificate or certificates representing
the Shares in the name specified below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">__________________________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holder&#146;s Name </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">__________________________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">__________________________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(Address) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;By its execution below and for the benefit of the Company, Holder hereby restates each of the representations and
warranties in Section&nbsp;4 of the Warrant to Purchase Stock as of the date hereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">HOLDER: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">_______________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">By:_________________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Name:________________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Title:_________________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(Date):_______________________________ </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Appendix 1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Schedule 1 </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Representations and Warranties of the Company </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company is a corporation duly organized, validly existing and in good standing under the laws of the state of
Delaware and has all powers and authority, and all licenses, permits, franchises, authorizations, consents and approvals of all Governmental Authorities, required to own its property and conduct its business as now conducted. The Company is duly
qualified to transact business and is in good standing in every jurisdiction in which such qualification or good standing is required by applicable law (except where the failure to be so qualified or in good standing would not result in, and could
not reasonably be expected to have resulted in a Material Adverse Effect). As used herein: (i) &#147;<U>Material Adverse Effect</U>&#148; means (a)&nbsp;an Insolvency Event, (b)&nbsp;a material adverse change in the business, operations, properties,
results of operations or financial condition of the Company, taken as a whole; (c)&nbsp;a material adverse effect on the validity or enforceability of the Transaction Documents taken as a whole or any material provision hereof or thereof; (d)&nbsp;a
material adverse effect on the ability of any Transaction Party to consummate the transactions contemplated by the Transaction Documents, or on the ability of any Transaction Party to perform its obligations under the Transaction Documents to which
it is a party; or (e)&nbsp;a material adverse effect on the rights or remedies of the Holder, the Administrative Agent or the Lenders under any of the Transaction Documents, taken as a whole and (ii) &#147;<U>Transaction Documents</U>&#148; mean the
Loan Documents together with the Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;None of the execution and delivery by the Company of any of the
Transaction Documents to which Parent is party, the performance by the Company of the obligations contemplated hereby or thereby or the consummation of the transactions contemplated hereby or thereby will: (i)&nbsp;contravene, conflict with, result
in a breach, violation, cancellation or termination of, constitute a default (with or without notice or lapse of time, or both) under, require prepayment under, give any Person the right to exercise any remedy (including termination, cancellation or
acceleration) or obtain any additional rights under, or accelerate the maturity or performance of or payment under, in any respect, (A)&nbsp;any Applicable Law or any judgment, order, writ, decree, permit or license of any Governmental Authority to
which the Company or any of its Subsidiaries or any of their respective assets or properties may be subject or bound, (B)&nbsp;any term or provision of any contract, agreement, indenture, lease, license, deed, commitment, obligation or instrument to
which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries or any of their respective assets or properties is bound or committed or (C)&nbsp;any term or provision of any of the organizational documents
of the Company or any of its Subsidiaries, except in the case of clause (A)&nbsp;or (B) where any such event would not result in a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company has all powers and authority to execute and deliver, and perform its obligations under, the Transaction
Documents to which it is party and to consummate the transactions contemplated hereby and thereby. The execution and delivery of each of the Transaction Documents to which the Company is party and the performance by the Company of its obligations
hereunder and thereunder have been duly authorized by the Company. Each of the Transaction Documents to which the Company is party has been duly executed and delivered by the Company. Each of the Transaction Documents to which the Company is party
constitutes the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its respective terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or similar Applicable Laws
affecting creditors&#146; rights generally, general equitable principles and principles of public policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The
execution and delivery by the Company of the Transaction Documents to which the Company is party, the performance by the Company of its obligations hereunder and thereunder and the consummation of any of the transactions contemplated hereunder and
thereunder do not require any consent, approval, license, order, authorization or declaration from, notice to, action or registration by or filing with any Governmental Authority or any other Person, except for the filing of (i)&nbsp;any applicable
notices under securities laws and (ii)&nbsp;those previously obtained and in full force and effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;There is
no action, suit, arbitration proceeding, claim, citation, summons, subpoena, investigation or other proceeding (whether civil, criminal, administrative, regulatory, investigative or informal, and including by or before a Governmental Authority)
pending or, to the knowledge of the Company, threatened in writing (or, in the case of a threat by a Governmental Authority, threatened orally or in writing) by or against the Company or any of its Subsidiaries, at law or in equity, that (i)&nbsp;if
adversely determined, would result in a Material Adverse Effect or (ii)&nbsp;challenges or seeks to prevent or delay the consummation of any of the transactions contemplated by any of the Transaction Documents to which the Company is party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 1.1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Upon consummation of the transactions contemplated by the
Transaction Documents and the application of the proceeds of the Term Loan to be made on the Closing Date, (a)&nbsp;the present fair saleable value of the properties and assets of the Company will be greater than the sum of its debts, liabilities
and other obligations, including contingent liabilities, (b)&nbsp;the present fair saleable value of the properties and assets of the Company will not be less than the amount that would be required to pay its probable liabilities on its existing
debts, liabilities and other obligations, including contingent liabilities, as they become absolute and matured, (c)&nbsp;the Company will be generally able to realize upon its assets and pay its debts, liabilities and other obligations, including
contingent obligations, as they become absolute and matured, (d)&nbsp;the Company will not have unreasonably small capital with which to engage in its business as now conducted, (e)&nbsp;the Company has not incurred, will not incur and does not have
any present plans or intentions to incur debts or other obligations or liabilities beyond its ability to pay such debts or other obligations or liabilities as they become absolute and matured, (f)&nbsp;the Company will not have become subject to any
Insolvency Event and (g)&nbsp;the Company will not have been rendered insolvent within the meaning of any Applicable Law. No step has been taken by the Company or, to its knowledge, any other Person to make the Company subject to an Insolvency
Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;No Default or Event of Default has occurred and is continuing, and no such event will occur upon the
making of the Term Loan to be made on the applicable Credit Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;The Company has timely filed (or caused to
be filed) all Tax returns and reports required by Applicable Law to have been filed by it and has paid all Taxes required to be paid by it (including in its capacity as a withholding agent), except any such Taxes that are being contested in good
faith by appropriate proceedings and for which adequate reserves in accordance with GAAP have been set aside on its books or where any such failure to file or pay would not result, individually or in the aggregate, in a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;None of the Company or any of its Subsidiaries (a)&nbsp;has violated or is in violation of, is under investigation
with respect to or has been threatened to be charged with or been given notice of any violation of, any Applicable Law or any judgment, order, writ, decree, injunction, stipulation, consent order, permit or license granted, issued or entered by any
Governmental Authority or (b)&nbsp;is subject to any judgment, order, writ, decree, injunction, stipulation, consent order, permit or license granted, issued or entered by any Governmental Authority, in each case, that would result in a Material
Adverse Effect. Each of the Company and any Subsidiary of the Company is in compliance with the requirements of all Applicable Laws, a breach of any of which would result in a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries is an &#147;investment company&#148;, or a company
&#147;controlled&#148; by an &#147;investment company&#148;, within the meaning of the Investment Company Act of 1940. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;The Financial Statements are complete and accurate in all material respects, were prepared in conformity with GAAP
applied on a consistent basis during the periods involved (except as may be indicated in the notes thereto) and present fairly in all material respects, in accordance with applicable requirements of GAAP, the consolidated financial position and the
consolidated financial results of the operations of the Company and its Subsidiaries as of the dates and for the periods covered thereby and the consolidated statements of cash flows of the Company and its Subsidiaries for the periods presented
therein. Since December&nbsp;31, 2021, there has been no Material Adverse Effect. The Company and its Subsidiaries have no Indebtedness (or other liabilities) other than (i)&nbsp;identified in the Financial Statements or (ii)&nbsp;incurred by the
Company or its Subsidiaries in the ordinary course of business since December&nbsp;31, 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;Neither the
Company nor any of the directors, officers, employees or, to the Company&#146;s knowledge, agents of the Company have, directly or indirectly, made, offered, promised or authorized any payment or gift of any money or anything of value to or for the
benefit of any &#147;foreign official&#148; (as such term is defined in the FCPA), foreign political party or official thereof or candidate for foreign political office for the purpose of (i)&nbsp;influencing any official act or decision of such
official, party or candidate, including inducing such official, party or candidate to do or omit to do any act in violation of such person&#146;s lawful duty; (ii)&nbsp;inducing such official, party or candidate to use such person&#146;s influence
to affect any act or decision of a foreign governmental authority, or (iii)&nbsp;otherwise securing any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 1.1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
improper advantage, in the case of (i), (ii) and (iii)&nbsp;above in order to assist the Company or any of its affiliates in obtaining or retaining business for or with, or directing business to,
any person. Neither the Company nor any of its directors, officers, employees or, to the Company&#146;s knowledge, agents have made or authorized any bribe, rebate, payoff, influence payment, kickback or other unlawful payment of funds or received
or retained any funds in violation of any law, rule or regulation. Neither the Company nor, to the Company&#146;s knowledge, any of its officers, directors or employees are the subject of any allegation, voluntary disclosure, investigation,
prosecution or other enforcement action related to the FCPA or any other anti-corruption law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;The Company, its
Subsidiaries, their respective directors, officers, employees, and, to the knowledge of the foregoing, agents of the same are and for the past five years have been in compliance with applicable laws and regulations pertaining to export controls and
trade and economic sanctions, including those administered and enforced by the U.S. Department of Commerce, U.S. Department of State, and U.S. Department of the Treasury (collectively, &#147;<U>Trade Control Laws</U>&#148;). None of the Company, its
Subsidiaries, or their respective directors, officers, employees, or, to the Company&#146;s knowledge, the Company&#146;s or it Subsidiaries&#146; agents is: (i)&nbsp;organized under the laws of, ordinarily resident in, or located in a country or
territory that is the subject of comprehensive Sanctions (which as of the date of this Agreement comprise Cuba, Iran, North Korea, Syria, and the Crimea, Donetsk People&#146;s Republic, and Luhansk People&#146;s Republic regions of Ukraine (each a
&#147;<U>Sanctioned Country</U>&#148;)); (ii) 50% or more owned or controlled by the government of a Sanctioned Country; or (iii)&nbsp;(A) designated on a sanctioned parties list administered by the United States or other applicable government
authority, including, without limitation, the U.S. Department of the Treasury&#146;s Office of Foreign Assets Control&#146;s Specially Designated Nationals and Blocked Persons List or Foreign Sanctions Evaders List ( &#147;<U>Listed
Parties</U>&#148;); or (B) 50% or more owned or, where relevant under applicable Trade Control Laws, controlled, individually or in the aggregate, by one or more Listed Parties (collectively, &#147;<U>Sanctioned Parties</U>&#148;). The Company has
obtained all export licenses and other approvals, and timely made all filings, in each case to the extent required pursuant to applicable Trade Control Laws. There are no pending or, to the Company&#146;s knowledge, threatened claims or
investigations against the Company with respect to Trade Control Laws, and no actions, conditions, or circumstances pertaining to the Company&#146;s activities that would reasonably be expected to give rise to any material future claims. The Company
shall not directly or indirectly use the proceeds of this transaction or lend, contribute, or otherwise make available such proceeds to any Sanctioned Country or Sanctioned Party, or in any manner that will result in a violation of Trade Control
Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;The underlying assets of the Company and its Subsidiaries do not constitute Plan Assets. The execution,
delivery and performance of this Agreement and the other Loan Documents do not and will not constitute a <FONT STYLE="white-space:nowrap">non-exempt</FONT> prohibited transaction under Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Internal
Revenue Code, or similar laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp;At no time in the past six years has the Company, its Subsidiaries or any ERISA
Affiliates maintained or contributed to, been required to maintain or contribute to, or otherwise had any liability (contingent or otherwise) with respect to any Employee Benefit Plan subject to Title IV of ERISA, Section&nbsp;302 of ERISA or the
minimum funding requirements of Section&nbsp;412 of the Code, or a &#147;multiemployer plan&#148; (as defined in Section&nbsp;3(37) of ERISA). As used herein, &#147;<U>ERISA Affiliate</U>&#148; means, as applied to any Person, (a)&nbsp;any
corporation which is a member of a controlled group of corporations within the meaning of Section&nbsp;414(b) of the Internal Revenue Code of which that Person is a member; (b)&nbsp;any trade or business (whether or not incorporated) which is a
member of a group of trades or businesses under common control within the meaning of Section&nbsp;414(c) of the Internal Revenue Code of which that Person is a member; and (c)&nbsp;any member of an affiliated service group within the meaning of
Section&nbsp;414(m) or (o)&nbsp;of the Internal Revenue Code of which that Person, any corporation described in clause (a)&nbsp;above or any trade or business described in clause (b)&nbsp;above is a member. Any former ERISA Affiliate of Borrower or
any of its Subsidiaries shall continue to be considered an ERISA Affiliate of Borrower or any such Subsidiary within the meaning of this definition with respect to the period such entity was an ERISA Affiliate of Borrower or such Subsidiary and with
respect to liabilities arising after such period for which Borrower or such Subsidiary could be liable under the Internal Revenue Code or ERISA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p)&nbsp;&nbsp;&nbsp;&nbsp;All written information heretofore or herein supplied by the Company to the Holder, Administrative Agent or any
Lender is accurate and complete in all material respects. There is no fact or circumstance known to the Company that could reasonably be expected to have a Material Adverse Effect that has not been expressly disclosed to the Holder, the
Administrative Agent and each Lender or in required reports and other information filed with the SEC under the Act and the Exchange Act (to the extent publicly available). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 1.1 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>d669381dex42.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#147;<B><U>ACT</U></B>&#148;), OR
THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND
SUBSTANCE SATISFACTORY TO THE ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WARRANT TO PURCHASE
STOCK </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Warrant No.:</B> [&#9679;] </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Company:</B>
XOMA Corporation, a Delaware corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Number of Shares:</B> [&#9679;], subject to adjustment </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Type/Series of Stock:</B> Common Stock, $0.0075 par value per share </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Warrant Price:</B> $42.50 per share, subject to adjustment </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Issue Date:</B> December&nbsp;15, 2023 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Expiration
Date:</B> December&nbsp;15, 2033 <B>See also Section</B><B></B><B>&nbsp;5.1(b).</B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Credit Facility:</B> This Warrant to Purchase Stock
(&#147;<B><U>Warrant</U></B>&#148;) is issued in connection with that certain Loan Agreement, of even date herewith, among XRL 1 LLC, as borrower, the lenders from time to time party thereto and Blue Owl Capital Corporation, as administrative agent
(as may be further amended and/or modified and in effect from time to time, the &#147;<B><U>Loan Agreement</U></B>&#148;; capitalized terms used herein but not defined herein shall have the meaning set forth in the Loan Agreement). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS WARRANT CERTIFIES THAT, for good and valuable consideration, [BLUE OWL CAPITAL CORPORATION] (together with any successor or permitted
assignee or transferee of this Warrant or of any shares issued upon exercise hereof, &#147;<B><U>Holder</U></B>&#148;) is entitled to purchase up to such number of fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> shares (the
&#147;<B><U>Shares</U></B>&#148;) of the above-stated Type/Series of Stock (the &#147;<B><U>Class</U></B>&#148;) of the above-named company (the &#147;<B><U>Company</U></B>&#148;), at the above-stated Warrant Price, all as set forth above and
subject to the provisions and upon the terms and conditions set forth in this Warrant. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SECTION 1. <U>EXERCISE</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1&nbsp;&nbsp;&nbsp;&nbsp;<U>Method of Exercise</U>. Holder may at any time and from time to time exercise this Warrant, in whole or in part,
by delivering to the Company the original of this Warrant together with a duly executed Notice of Exercise in substantially the form attached hereto as Appendix 1 and, unless Holder is exercising this Warrant pursuant to a cashless exercise set
forth in Section&nbsp;1.2, a check, wire transfer of <FONT STYLE="white-space:nowrap">same-day</FONT> funds (to an account designated by the Company), or other form of payment acceptable to the Company for the aggregate Warrant Price for the Shares
being purchased. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2&nbsp;&nbsp;&nbsp;&nbsp;<U>Cashless Exercise</U>. On any exercise of this Warrant, in lieu of payment of the
aggregate Warrant Price in the manner as specified in Section&nbsp;1.1 above, but otherwise in accordance with the requirements of Section&nbsp;1.1, Holder may elect to receive Shares equal to the value of this Warrant, or portion hereof as to which
this Warrant is being exercised. Thereupon, the Company shall issue to the Holder such number of fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> Shares as are computed using the following formula: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">X = <FONT STYLE="white-space:nowrap">Y(A-B)/A</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">where: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">X = the
number of Shares to be issued to the Holder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Y = the number of Shares with respect to which this Warrant is being
exercised (inclusive of the Shares surrendered to the Company in payment of the aggregate Warrant Price); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">A = the Fair
Market Value (as determined pursuant to Section&nbsp;1.3 below) of one Share; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">B = the Warrant Price. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.3&nbsp;&nbsp;&nbsp;&nbsp;<U>Fair Market Value</U>. If shares of the Class&nbsp;are then
traded or quoted on a nationally recognized securities exchange, inter-dealer quotation system or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market (a &#147;<B><U>Trading Market</U></B>&#148;),
the fair market value of a Share shall be the closing price or last sale price of a share of the Class&nbsp;reported for the Business Day immediately before the date on which Holder delivers this Warrant together with its Notice of Exercise to the
Company. If shares of the Class&nbsp;are not then traded in a Trading Market, the Board of Directors of the Company shall determine the fair market value of a Share in its reasonable good faith judgment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.4&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery of Certificate and New Warrant</U>. Within a reasonable time after Holder exercises this Warrant in the
manner set forth in Section&nbsp;1.1 or 1.2 above, the Company shall deliver to Holder a certificate representing the Shares issued to Holder upon such exercise (which certificate may be in the form of an electronic certificate or DTC entry, to the
extent used by the Company at the time of such exercise) and, if this Warrant has not been fully exercised and has not expired, a new warrant of like tenor representing the Shares not so acquired. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.5&nbsp;&nbsp;&nbsp;&nbsp;<U>Replacement of Warrant</U>. On receipt of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form, substance and amount to the Company or, in the case of mutilation, on surrender of this
Warrant to the Company for cancellation, the Company shall, within a reasonable time, execute and deliver to Holder, in lieu of this Warrant, a new warrant of like tenor and amount. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.6&nbsp;&nbsp;&nbsp;&nbsp;<U>Treatment of Warrant Upon Acquisition of Company</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Acquisition</U>. For the purpose of this Warrant, &#147;<B><U>Acquisition</U></B>&#148; means any
transaction or series of related transactions involving: (i)&nbsp;the sale, lease, exclusive license, or other disposition of all or substantially all of the assets of the Company; (ii)&nbsp;any merger or consolidation of the Company into or with
another person or entity (other than a merger or consolidation effected exclusively to change the Company&#146;s domicile), or any other corporate reorganization, in which the stockholders of the Company in their capacity as such immediately prior
to such merger, consolidation or reorganization, own less than a majority of the Company&#146;s (or the surviving or successor entity&#146;s) outstanding voting power immediately after such merger, consolidation or reorganization (or, if such
Company stockholders beneficially own a majority of the outstanding voting power of the surviving or successor entity as of immediately after such merger, consolidation or reorganization, such surviving or successor entity is not the Company); or
(iii)&nbsp;any sale or other transfer by the stockholders of the Company of shares representing at least a majority of the Company&#146;s then-total outstanding combined voting power. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Treatment of Warrant at Acquisition</U>. In the event of an Acquisition in which the
consideration to be received by the Company&#146;s stockholders consists solely of cash, solely of Marketable Securities or a combination of cash and Marketable Securities (a &#147;<B><U>Cash/Public Acquisition</U></B>&#148;), and the fair market
value of one Share as determined in accordance with Section&nbsp;1.3 above would be greater than the Warrant Price in effect on such date immediately prior to such Cash/Public Acquisition, and Holder has not exercised this Warrant pursuant to
Section&nbsp;1.1 above as to all Shares, then this Warrant shall automatically be deemed to be Cashless Exercised pursuant to Section&nbsp;1.2 above as to all Shares effective immediately prior to and contingent upon the consummation of a
Cash/Public Acquisition. In connection with such Cashless Exercise, Holder shall be deemed to have restated each of the representations and warranties in Section&nbsp;4 of the Warrant as of the date thereof and the Company shall promptly notify the
Holder of the number of Shares (or such other securities) issued upon exercise. In the event of a Cash/Public Acquisition where the fair market value of one Share as determined in accordance with Section&nbsp;1.3 above would be less than the Warrant
Price in effect immediately prior to such Cash/Public Acquisition, then this Warrant will expire immediately prior to the consummation of such Cash/Public Acquisition. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Upon the closing of any Acquisition other than a Cash/Public Acquisition, the acquiring, surviving
or successor entity shall assume the obligations of this Warrant, and this Warrant shall thereafter be exercisable for the same securities and/or other property as would have been paid for the Shares issuable upon exercise of the unexercised portion
of this Warrant as if such Shares were outstanding on and as of the closing of such Acquisition, subject to further adjustment from time to time in accordance with the provisions of this Warrant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;As used in this Warrant, &#147;<B><U>Marketable
Securities</U></B>&#148; means securities meeting all of the following requirements: (i)&nbsp;the issuer thereof is then subject to the reporting requirements of Section&nbsp;13 or Section&nbsp;15(d) of the Securities Exchange Act of 1934, as
amended (the &#147;<B><U>Exchange Act</U></B>&#148;), and is then current in its filing of all required reports and other information under the Act and the Exchange Act; (ii)&nbsp;the class and series of shares or other security of the issuer that
would be received by Holder in connection with the Acquisition were Holder to exercise this Warrant on or prior to the closing thereof is then traded in a Trading Market, and (iii)&nbsp;following the closing of such Acquisition, Holder would not be
restricted from publicly <FONT STYLE="white-space:nowrap">re-selling</FONT> all of the issuer&#146;s shares and/or other securities that would be received by Holder in such Acquisition were Holder to exercise this Warrant in full on or prior to the
closing of such Acquisition, except to the extent that any such restriction (x)&nbsp;arises solely under federal or state securities laws, rules or regulations, and (y)&nbsp;does not extend beyond six (6)&nbsp;months from the closing of such
Acquisition. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SECTION 2. <U>ADJUSTMENTS TO THE SHARES</U> <U>AND WARRANT PRICE</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock Dividends, Splits, Etc</U>. If the Company declares or pays a dividend or distribution on the outstanding
shares of the Class&nbsp;payable in additional shares of the Class&nbsp;or other securities or property (other than cash), then upon exercise of this Warrant, for each Share acquired, Holder shall receive, without additional cost to Holder, the
total number and kind of securities and property which Holder would have received had Holder owned the Shares of record as of the date the dividend or distribution occurred. If the Company subdivides the outstanding shares of the Class&nbsp;by
reclassification or otherwise into a greater number of shares, the number of Shares purchasable hereunder shall be proportionately increased and the Warrant Price shall be proportionately decreased. If the outstanding shares of the Class&nbsp;are
combined or consolidated, by reclassification or otherwise, into a lesser number of shares, the Warrant Price shall be proportionately increased and the number of Shares shall be proportionately decreased. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2&nbsp;&nbsp;&nbsp;&nbsp;<U>Reclassification, Exchange, Combinations or Substitution</U>. Upon any event whereby all of the outstanding
shares of the Class&nbsp;are reclassified, exchanged, combined, substituted, or replaced for, into, with or by Company securities of a different class and/or series, then from and after the consummation of such event, this Warrant will be
exercisable for the number, class and series of Company securities that Holder would have received had the Shares been outstanding on and as of the consummation of such event, and subject to further adjustment thereafter from time to time in
accordance with the provisions of this Warrant. The provisions of this Section&nbsp;2.2 shall similarly apply to successive reclassifications, exchanges, combinations, substitutions, replacements or other similar events. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3&nbsp;&nbsp;&nbsp;&nbsp;<U>No </U><U>Fractional </U><U>Share</U>. No fractional Share shall be issuable upon exercise of this Warrant and
the number of Shares to be issued shall be rounded down to the nearest whole Share. If a fractional Share interest arises upon any exercise of the Warrant, the Company shall eliminate such fractional Share interest by paying Holder in cash the
amount computed by multiplying the fractional interest by (i)&nbsp;the fair market value (as determined in accordance with Section&nbsp;1.3 above) of a full Share, less (ii)&nbsp;the then-effective Warrant Price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice/Certificate as to Adjustments</U>. Upon each adjustment of the Warrant Price, Class&nbsp;and/or number of
Shares, the Company, at the Company&#146;s expense, shall notify Holder in writing within a reasonable time setting forth the adjustments to the Warrant Price, Class&nbsp;and/or number of Shares and facts upon which such adjustment is based. The
Company shall, upon written request from Holder, furnish Holder with a certificate of its Chief Financial Officer, including computations of such adjustment and the Warrant Price, Class&nbsp;and number of Shares in effect upon the date of such
adjustment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Treatment as to Adjustments</U>. The Company acknowledges its obligations to file and/or
publicly post (as applicable) an IRS Form 8937 (or similar tax form) if an adjustment (or lack thereof) to the Warrant entitlement results in a distribution under Section&nbsp;305(c) of the Internal Revenue Code of 1986, as amended, and agrees to
notify Holder on a timely basis in the event of such an adjustment (or lack thereof) and, in the case of any required IRS Form 8937 filing, consider, in good faith, any timely received, reasonable written comments of Holder in preparing such IRS
Form 8937. For the avoidance of doubt, if there is more than one permissible method to determine the amount of the constructive dividend for tax purposes, unless Holder gives notice otherwise, the Company agrees to select the method that results in
the lowest constructive dividend amount as long as such method is at a &#147;more likely than not&#148; level of comfort. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SECTION 3. <U>REPRESENTATIONS AND COVENANTS OF THE COMPANY</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations and Warranties</U>. The Company represents and warrants to, and agrees with, the Holder as
follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;All Shares which may be issued upon the exercise of this Warrant shall, upon issuance,
be duly authorized, validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable,</FONT> and free of any liens and encumbrances except for restrictions on transfer provided for herein or under applicable federal and state
securities laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company covenants that it shall at all times cause to be reserved and kept
available out of its authorized and unissued capital stock such number of shares of the Class&nbsp;and other securities as will be sufficient to permit the exercise in full of this Warrant. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;As of the date hereof, each representation and warranty set forth on Schedule 1 hereto is true and
correct. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice of Certain Events</U>. If the Company proposes at any time to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;declare any dividend or distribution upon the outstanding shares of the Class, whether in cash,
property, stock, or other securities and whether or not a regular cash dividend; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;offer for
subscription or sale pro rata to the holders of the outstanding shares of the Class&nbsp;any additional shares of any class or series of the Company&#146;s stock (other than pursuant to contractual <FONT STYLE="white-space:nowrap">pre-emptive</FONT>
rights); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;effect any reclassification, exchange, combination, substitution, reorganization or
recapitalization of the outstanding shares of the Class; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;effect an Acquisition or to
liquidate, dissolve or wind up; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">then, in connection with each such event, the Company shall give Holder notice thereof at the same time
and in the same manner as given to holders of the outstanding shares of the Class. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3&nbsp;&nbsp;&nbsp;&nbsp;<U>Direction to Transfer
Agent</U>. Upon each exercise of the Warrant (in whole or in part), the Company shall promptly deliver irrevocable authorization and direction to its transfer agent to issue book-entry statements representing the Shares. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SECTION 4. <U>REPRESENTATIONS AND WARRANTIES OF THE HOLDER.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Holder represents and warrants to the Company as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase for Own Account</U>. This Warrant and the Shares to be acquired upon exercise of this Warrant by Holder
are being acquired for investment for Holder&#146;s account, not as a nominee or agent, and not with a view to the public resale or distribution within the meaning of the Act. Holder also represents that it has not been formed for the specific
purpose of acquiring this Warrant or the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2&nbsp;&nbsp;&nbsp;&nbsp;<U>Disclosure of Information</U>. Holder is aware of the
Company&#146;s business affairs and financial condition and has received or has had full access to all the information it considers necessary or appropriate to make an informed investment decision with respect to the acquisition of this Warrant and
its underlying securities. Holder further has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the offering of this Warrant and its underlying securities and to obtain additional
information (to the extent the Company possessed such information or could acquire it without unreasonable effort or expense) necessary to verify any information furnished to Holder or to which Holder has access. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3&nbsp;&nbsp;&nbsp;&nbsp;<U>Investment Experience</U>. Holder understands that the
purchase of this Warrant and its underlying securities involves substantial risk. Holder has experience as an investor in securities of companies in the development stage and acknowledges that Holder can bear the economic risk of such Holder&#146;s
investment in this Warrant and its underlying securities and has such knowledge and experience in financial or business matters that Holder is capable of evaluating the merits and risks of its investment in this Warrant and its underlying securities
and/or has a preexisting personal or business relationship with the Company and certain of its officers, directors or controlling persons of a nature and duration that enables Holder to be aware of the character, business acumen and financial
circumstances of such persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.4&nbsp;&nbsp;&nbsp;&nbsp;<U>Accredited Investor Status</U>. Holder is an &#147;accredited investor&#148;
within the meaning of Regulation D promulgated under the Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.5&nbsp;&nbsp;&nbsp;&nbsp;<U>The Act</U>. Holder understands that this
Warrant and the Shares issuable upon exercise hereof have not been registered under the Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of the Holder&#146;s investment
intent as expressed herein. Holder understands that this Warrant and the Shares issued upon any exercise hereof must be held indefinitely unless subsequently registered under the Act and qualified under applicable state securities laws, or unless
exemption from such registration and qualification are otherwise available. Holder is aware of the provisions of Rule 144 promulgated under the Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.6&nbsp;&nbsp;&nbsp;&nbsp;<U>No Shareholder Rights</U>. Without limiting any provision of this Warrant, Holder agrees that as a Holder of
this Warrant it will not have any rights (including, but not limited to, voting rights) as a shareholder of the Company with respect to the Shares issuable hereunder unless and until the exercise of this Warrant and then only with respect to the
Shares issued on such exercise. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SECTION 5. <U>MISCELLANEOUS</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1&nbsp;&nbsp;&nbsp;&nbsp;<U>Term; Automatic Cashless Exercise Upon Expiration</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Term</U>. Subject to the provisions of Section&nbsp;1.6 above, this Warrant is exercisable in
whole or in part at any time and from time to time on or before 6:00 PM, Pacific time, on the Expiration Date and shall be void thereafter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Automatic Cashless Exercise upon Expiration</U>. In the event that, upon the Expiration Date, the
fair market value of one Share as determined in accordance with Section&nbsp;1.3 above is greater than the Warrant Price in effect on such date, then this Warrant shall automatically be deemed on and as of such date to be exercised pursuant to
Section&nbsp;1.2 above as to all Shares for which it shall not previously have been exercised, and the Company shall, within a reasonable time, deliver a certificate representing the Shares issued upon such exercise to Holder (which certificate may
be in the form of an electronic certificate or DTC entry, to the extent used by the Company at the time of such exercise). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2&nbsp;&nbsp;&nbsp;&nbsp;<U>Legends</U>. Each certificate evidencing Shares shall be imprinted with a legend in substantially the following
form: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">THE SHARES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
&#147;<B><U>ACT</U></B>&#148;), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN THAT CERTAIN WARRANT TO PURCHASE STOCK ISSUED BY THE ISSUER TO [BLUE OWL CAPITAL CORPORATION] DATED DECEMBER&nbsp;15, 2023, MAY NOT BE OFFERED, SOLD,
PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance with Securities Laws on Transfer</U>. This Warrant and the Shares issued upon exercise of this
Warrant may not be transferred or assigned in whole or in part except in compliance with applicable federal and state securities laws by the transferor and the transferee (including, without limitation, the delivery of investment representation
letters and legal opinions reasonably satisfactory to the Company, as reasonably requested by the Company). The Company shall not require Holder to provide an opinion of counsel if the transfer is to an affiliate of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Holder, provided that any such transferee is an &#147;accredited investor&#148; as defined in Regulation D promulgated under the Act. Additionally, the Company shall also not require an opinion
of counsel if there is no material question as to the availability of Rule 144 promulgated under the Act. For purposes of an affiliate transfer contemplated herein, the Company hereby approves each and every registered investment company, private
equity fund, venture capital fund, private or similar collective investment vehicle now or hereafter existing that is controlled by one or more affiliated general partners, managing members or investment advisers of, or shares an affiliated
management company or investment adviser with, the Holder as an &#147;affiliate&#148; of the Holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfer Procedure</U>. Subject to the provisions of Section&nbsp;5.3 and upon providing the Company with
written notice, [Blue Owl Capital Corporation] and any subsequent Holder may transfer all or part of this Warrant to any transferee, provided, however, in connection with any such transfer, [Blue Owl Capital Corporation] or any subsequent Holder
will give the Company notice of the portion of the Warrant being transferred with the name, address and taxpayer identification number of the transferee and Holder will surrender this Warrant to the Company for reissuance to the transferee(s) (and
Holder if applicable); and provided further, that any subsequent transferee of this Warrant or of any portion hereof shall agree in writing with the Company to be bound by all of the terms and conditions of this Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.5&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>. All notices and other communications hereunder from the Company to the Holder, or vice versa, shall
be deemed delivered and effective (i)&nbsp;when given personally, (ii)&nbsp;on the third (3rd) Business Day after being mailed by first-class registered or certified mail, postage prepaid, (iii)&nbsp;upon actual receipt if given by electronic mail
and such receipt is confirmed in writing by the recipient, or (iv)&nbsp;on the first Business Day following delivery to a reliable overnight courier service, courier fee prepaid, in any case at such address as may have been furnished to the Company
or Holder, as the case may be, in writing by the Company or such Holder from time to time in accordance with the provisions of this Section&nbsp;5.5. All notices to Holder shall be addressed as follows until the Company receives notice of a change
of address in connection with a transfer or otherwise: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[Holder] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">c/o Blue Owl Capital Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">399 Park Avenue, 37th Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New
York, NY 10022 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Telephone: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Email address: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">with a copy
(which shall not constitute notice) to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cooley LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attn: Michael Tollini </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1299
Pennsylvania Avenue, NW, Suite 700 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Washington, DC 20004-2400 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Email: &nbsp;&nbsp;&nbsp;&nbsp;mtollini@cooley.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice to the Company shall be addressed as follows until Holder receives notice of a change in address: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">XOMA Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attn: Chief
Financial Officer </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2200 Powell Street, Suite 310 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Emeryville, CA 94608 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Telephone:
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Email: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With a copy (which
shall not constitute notice) to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gibson, Dunn&nbsp;&amp; Crutcher LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attn: Ryan Murr and Branden Berns </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">555 Mission Street, Suite #3000 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">San Francisco, CA 94105 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Telephone: (415) <FONT STYLE="white-space:nowrap">393-8373;</FONT> (415) <FONT STYLE="white-space:nowrap">393-4631</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Email: <U>rmurr@gibsondunn.com</U>; <U>bberns@gibsondunn.com</U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.6&nbsp;&nbsp;&nbsp;&nbsp;<U>Waiver</U>. This Warrant and any term hereof may be changed,
waived, discharged or terminated (either generally or in a particular instance and either retroactively or prospectively) only by an instrument in writing signed by the party against which enforcement of such change, waiver, discharge or termination
is sought. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.7&nbsp;&nbsp;&nbsp;&nbsp;<U>Attorneys</U><U>&#146;</U><U> Fees</U>. In the event of any dispute between the parties
concerning the terms and provisions of this Warrant, the party prevailing in such dispute shall be entitled to collect from the other party all costs incurred in such dispute, including reasonable attorneys&#146; fees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.8&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts</U><U>; Facsimile/Electronic Signatures</U>. This Warrant may be executed in counterparts, all of
which together shall constitute one and the same agreement. Any signature page delivered electronically or by facsimile shall be binding to the same extent as an original signature page with regards to any agreement subject to the terms hereof or
any amendment thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.9&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing Law</U>. This Warrant shall be governed by and construed in accordance
with the laws of the State of New York, without giving effect to its principles regarding conflicts of law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.10&nbsp;&nbsp;&nbsp;&nbsp;<U>Headings</U>. The headings in this Warrant are for purposes of reference only and shall not limit or otherwise
affect the meaning of any provision of this Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.11&nbsp;&nbsp;&nbsp;&nbsp;<U>Business Days</U>. &#147;<B><U>Business
Day</U></B>&#148; is any day that is not a Saturday, Sunday or other day on which commercial banks in New York City are authorized or required by Applicable Law to remain closed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Remainder of page left blank intentionally] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature page follows] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties have caused this Warrant to Purchase Stock to be executed by
their duly authorized representatives effective as of the Issue Date written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#147;COMPANY&#148;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>XOMA CORPORATION</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Thomas Burns</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#147;HOLDER&#148;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>[BLUE OWL CAPITAL CORPORATION]</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">APPENDIX 1 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>NOTICE OF EXERCISE </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;The undersigned Holder hereby exercises its right to purchase ___________ shares of the Common/Series ______
Preferred [circle one] Stock of __________________ (the &#147;<B><U>Company</U></B>&#148;) in accordance with the attached Warrant To Purchase Stock, and tenders payment of the aggregate Warrant Price for such shares as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[ ]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;check in the amount of $________ payable to
order of the Company enclosed herewith </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[
]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Wire transfer of immediately available funds to the Company&#146;s account </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[ ]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cashless Exercise pursuant to
Section&nbsp;1.2 of the Warrant </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[ ]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
[Describe] __________________________________________ </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;Please issue a certificate or certificates representing
the Shares in the name specified below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">__________________________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holder&#146;s Name </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">__________________________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">__________________________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(Address) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;By its execution below and for the benefit of the Company, Holder hereby restates each of the representations and
warranties in Section&nbsp;4 of the Warrant to Purchase Stock as of the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">HOLDER: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">_______________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">By:_________________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Name:________________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Title:_________________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(Date):_______________________________ </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Appendix 1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Schedule 1 </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Representations and Warranties of the Company </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company is a corporation duly organized, validly existing and in good standing under the laws of the state of
Delaware and has all powers and authority, and all licenses, permits, franchises, authorizations, consents and approvals of all Governmental Authorities, required to own its property and conduct its business as now conducted. The Company is duly
qualified to transact business and is in good standing in every jurisdiction in which such qualification or good standing is required by applicable law (except where the failure to be so qualified or in good standing would not result in, and could
not reasonably be expected to have resulted in a Material Adverse Effect). As used herein: (i) &#147;<U>Material Adverse Effect</U>&#148; means (a)&nbsp;an Insolvency Event, (b)&nbsp;a material adverse change in the business, operations, properties,
results of operations or financial condition of the Company, taken as a whole; (c)&nbsp;a material adverse effect on the validity or enforceability of the Transaction Documents taken as a whole or any material provision hereof or thereof; (d)&nbsp;a
material adverse effect on the ability of any Transaction Party to consummate the transactions contemplated by the Transaction Documents, or on the ability of any Transaction Party to perform its obligations under the Transaction Documents to which
it is a party; or (e)&nbsp;a material adverse effect on the rights or remedies of the Holder, the Administrative Agent or the Lenders under any of the Transaction Documents, taken as a whole and (ii) &#147;<U>Transaction Documents</U>&#148; mean the
Loan Documents together with the Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;None of the execution and delivery by the Company of any of the
Transaction Documents to which Parent is party, the performance by the Company of the obligations contemplated hereby or thereby or the consummation of the transactions contemplated hereby or thereby will: (i)&nbsp;contravene, conflict with, result
in a breach, violation, cancellation or termination of, constitute a default (with or without notice or lapse of time, or both) under, require prepayment under, give any Person the right to exercise any remedy (including termination, cancellation or
acceleration) or obtain any additional rights under, or accelerate the maturity or performance of or payment under, in any respect, (A)&nbsp;any Applicable Law or any judgment, order, writ, decree, permit or license of any Governmental Authority to
which the Company or any of its Subsidiaries or any of their respective assets or properties may be subject or bound, (B)&nbsp;any term or provision of any contract, agreement, indenture, lease, license, deed, commitment, obligation or instrument to
which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries or any of their respective assets or properties is bound or committed or (C)&nbsp;any term or provision of any of the organizational documents
of the Company or any of its Subsidiaries, except in the case of clause (A)&nbsp;or (B) where any such event would not result in a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company has all powers and authority to execute and deliver, and perform its obligations under, the Transaction
Documents to which it is party and to consummate the transactions contemplated hereby and thereby. The execution and delivery of each of the Transaction Documents to which the Company is party and the performance by the Company of its obligations
hereunder and thereunder have been duly authorized by the Company. Each of the Transaction Documents to which the Company is party has been duly executed and delivered by the Company. Each of the Transaction Documents to which the Company is party
constitutes the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its respective terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or similar Applicable Laws
affecting creditors&#146; rights generally, general equitable principles and principles of public policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The
execution and delivery by the Company of the Transaction Documents to which the Company is party, the performance by the Company of its obligations hereunder and thereunder and the consummation of any of the transactions contemplated hereunder and
thereunder do not require any consent, approval, license, order, authorization or declaration from, notice to, action or registration by or filing with any Governmental Authority or any other Person, except for the filing of (i)&nbsp;any applicable
notices under securities laws and (ii)&nbsp;those previously obtained and in full force and effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;There is
no action, suit, arbitration proceeding, claim, citation, summons, subpoena, investigation or other proceeding (whether civil, criminal, administrative, regulatory, investigative or informal, and including by or before a Governmental Authority)
pending or, to the knowledge of the Company, threatened in writing (or, in the case of a threat by a Governmental Authority, threatened orally or in writing) by or against the Company or any of its Subsidiaries, at law or in equity, that (i)&nbsp;if
adversely determined, would result in a Material Adverse Effect or (ii)&nbsp;challenges or seeks to prevent or delay the consummation of any of the transactions contemplated by any of the Transaction Documents to which the Company is party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 1.1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Upon consummation of the transactions contemplated by the
Transaction Documents and the application of the proceeds of the Term Loan to be made on the Closing Date, (a)&nbsp;the present fair saleable value of the properties and assets of the Company will be greater than the sum of its debts, liabilities
and other obligations, including contingent liabilities, (b)&nbsp;the present fair saleable value of the properties and assets of the Company will not be less than the amount that would be required to pay its probable liabilities on its existing
debts, liabilities and other obligations, including contingent liabilities, as they become absolute and matured, (c)&nbsp;the Company will be generally able to realize upon its assets and pay its debts, liabilities and other obligations, including
contingent obligations, as they become absolute and matured, (d)&nbsp;the Company will not have unreasonably small capital with which to engage in its business as now conducted, (e)&nbsp;the Company has not incurred, will not incur and does not have
any present plans or intentions to incur debts or other obligations or liabilities beyond its ability to pay such debts or other obligations or liabilities as they become absolute and matured, (f)&nbsp;the Company will not have become subject to any
Insolvency Event and (g)&nbsp;the Company will not have been rendered insolvent within the meaning of any Applicable Law. No step has been taken by the Company or, to its knowledge, any other Person to make the Company subject to an Insolvency
Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;No Default or Event of Default has occurred and is continuing, and no such event will occur upon the
making of the Term Loan to be made on the applicable Credit Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;The Company has timely filed (or caused to
be filed) all Tax returns and reports required by Applicable Law to have been filed by it and has paid all Taxes required to be paid by it (including in its capacity as a withholding agent), except any such Taxes that are being contested in good
faith by appropriate proceedings and for which adequate reserves in accordance with GAAP have been set aside on its books or where any such failure to file or pay would not result, individually or in the aggregate, in a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;None of the Company or any of its Subsidiaries (a)&nbsp;has violated or is in violation of, is under investigation
with respect to or has been threatened to be charged with or been given notice of any violation of, any Applicable Law or any judgment, order, writ, decree, injunction, stipulation, consent order, permit or license granted, issued or entered by any
Governmental Authority or (b)&nbsp;is subject to any judgment, order, writ, decree, injunction, stipulation, consent order, permit or license granted, issued or entered by any Governmental Authority, in each case, that would result in a Material
Adverse Effect. Each of the Company and any Subsidiary of the Company is in compliance with the requirements of all Applicable Laws, a breach of any of which would result in a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries is an &#147;investment company&#148;, or a company
&#147;controlled&#148; by an &#147;investment company&#148;, within the meaning of the Investment Company Act of 1940. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;The Financial Statements are complete and accurate in all material respects, were prepared in conformity with GAAP
applied on a consistent basis during the periods involved (except as may be indicated in the notes thereto) and present fairly in all material respects, in accordance with applicable requirements of GAAP, the consolidated financial position and the
consolidated financial results of the operations of the Company and its Subsidiaries as of the dates and for the periods covered thereby and the consolidated statements of cash flows of the Company and its Subsidiaries for the periods presented
therein. Since December&nbsp;31, 2021, there has been no Material Adverse Effect. The Company and its Subsidiaries have no Indebtedness (or other liabilities) other than (i)&nbsp;identified in the Financial Statements or (ii)&nbsp;incurred by the
Company or its Subsidiaries in the ordinary course of business since December&nbsp;31, 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;Neither the
Company nor any of the directors, officers, employees or, to the Company&#146;s knowledge, agents of the Company have, directly or indirectly, made, offered, promised or authorized any payment or gift of any money or anything of value to or for the
benefit of any &#147;foreign official&#148; (as such term is defined in the FCPA), foreign political party or official thereof or candidate for foreign political office for the purpose of (i)&nbsp;influencing any official act or decision of such
official, party or candidate, including inducing such official, party or candidate to do or omit to do any act in violation of such person&#146;s lawful duty; (ii)&nbsp;inducing such official, party or candidate to use such person&#146;s influence
to affect any act or decision of a foreign governmental authority, or (iii)&nbsp;otherwise securing any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 1.1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
improper advantage, in the case of (i), (ii) and (iii)&nbsp;above in order to assist the Company or any of its affiliates in obtaining or retaining business for or with, or directing business to,
any person. Neither the Company nor any of its directors, officers, employees or, to the Company&#146;s knowledge, agents have made or authorized any bribe, rebate, payoff, influence payment, kickback or other unlawful payment of funds or received
or retained any funds in violation of any law, rule or regulation. Neither the Company nor, to the Company&#146;s knowledge, any of its officers, directors or employees are the subject of any allegation, voluntary disclosure, investigation,
prosecution or other enforcement action related to the FCPA or any other anti-corruption law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;The Company, its
Subsidiaries, their respective directors, officers, employees, and, to the knowledge of the foregoing, agents of the same are and for the past five years have been in compliance with applicable laws and regulations pertaining to export controls and
trade and economic sanctions, including those administered and enforced by the U.S. Department of Commerce, U.S. Department of State, and U.S. Department of the Treasury (collectively, &#147;<U>Trade Control Laws</U>&#148;). None of the Company, its
Subsidiaries, or their respective directors, officers, employees, or, to the Company&#146;s knowledge, the Company&#146;s or it Subsidiaries&#146; agents is: (i)&nbsp;organized under the laws of, ordinarily resident in, or located in a country or
territory that is the subject of comprehensive Sanctions (which as of the date of this Agreement comprise Cuba, Iran, North Korea, Syria, and the Crimea, Donetsk People&#146;s Republic, and Luhansk People&#146;s Republic regions of Ukraine (each a
&#147;<U>Sanctioned Country</U>&#148;)); (ii) 50% or more owned or controlled by the government of a Sanctioned Country; or (iii)&nbsp;(A) designated on a sanctioned parties list administered by the United States or other applicable government
authority, including, without limitation, the U.S. Department of the Treasury&#146;s Office of Foreign Assets Control&#146;s Specially Designated Nationals and Blocked Persons List or Foreign Sanctions Evaders List ( &#147;<U>Listed
Parties</U>&#148;); or (B) 50% or more owned or, where relevant under applicable Trade Control Laws, controlled, individually or in the aggregate, by one or more Listed Parties (collectively, &#147;<U>Sanctioned Parties</U>&#148;). The Company has
obtained all export licenses and other approvals, and timely made all filings, in each case to the extent required pursuant to applicable Trade Control Laws. There are no pending or, to the Company&#146;s knowledge, threatened claims or
investigations against the Company with respect to Trade Control Laws, and no actions, conditions, or circumstances pertaining to the Company&#146;s activities that would reasonably be expected to give rise to any material future claims. The Company
shall not directly or indirectly use the proceeds of this transaction or lend, contribute, or otherwise make available such proceeds to any Sanctioned Country or Sanctioned Party, or in any manner that will result in a violation of Trade Control
Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;The underlying assets of the Company and its Subsidiaries do not constitute Plan Assets. The execution,
delivery and performance of this Agreement and the other Loan Documents do not and will not constitute a <FONT STYLE="white-space:nowrap">non-exempt</FONT> prohibited transaction under Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Internal
Revenue Code, or similar laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp;At no time in the past six years has the Company, its Subsidiaries or any ERISA
Affiliates maintained or contributed to, been required to maintain or contribute to, or otherwise had any liability (contingent or otherwise) with respect to any Employee Benefit Plan subject to Title IV of ERISA, Section&nbsp;302 of ERISA or the
minimum funding requirements of Section&nbsp;412 of the Code, or a &#147;multiemployer plan&#148; (as defined in Section&nbsp;3(37) of ERISA). As used herein, &#147;<U>ERISA Affiliate</U>&#148; means, as applied to any Person, (a)&nbsp;any
corporation which is a member of a controlled group of corporations within the meaning of Section&nbsp;414(b) of the Internal Revenue Code of which that Person is a member; (b)&nbsp;any trade or business (whether or not incorporated) which is a
member of a group of trades or businesses under common control within the meaning of Section&nbsp;414(c) of the Internal Revenue Code of which that Person is a member; and (c)&nbsp;any member of an affiliated service group within the meaning of
Section&nbsp;414(m) or (o)&nbsp;of the Internal Revenue Code of which that Person, any corporation described in clause (a)&nbsp;above or any trade or business described in clause (b)&nbsp;above is a member. Any former ERISA Affiliate of Borrower or
any of its Subsidiaries shall continue to be considered an ERISA Affiliate of Borrower or any such Subsidiary within the meaning of this definition with respect to the period such entity was an ERISA Affiliate of Borrower or such Subsidiary and with
respect to liabilities arising after such period for which Borrower or such Subsidiary could be liable under the Internal Revenue Code or ERISA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p)&nbsp;&nbsp;&nbsp;&nbsp;All written information heretofore or herein supplied by the Company to the Holder, Administrative Agent or any
Lender is accurate and complete in all material respects. There is no fact or circumstance known to the Company that could reasonably be expected to have a Material Adverse Effect that has not been expressly disclosed to the Holder, the
Administrative Agent and each Lender or in required reports and other information filed with the SEC under the Act and the Exchange Act (to the extent publicly available). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 1.1 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>d669381dex43.htm
<DESCRIPTION>EX-4.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#147;<B><U>ACT</U></B>&#148;), OR
THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND
SUBSTANCE SATISFACTORY TO THE ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WARRANT TO PURCHASE
STOCK </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Warrant No.:</B> [&#9679;] </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Company:</B>
XOMA Corporation, a Delaware corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Number of Shares:</B> [&#9679;], subject to adjustment </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Type/Series of Stock:</B> Common Stock, $0.0075 par value per share </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Warrant Price:</B> $50.00 per share, subject to adjustment </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Issue Date:</B> December&nbsp;15, 2023 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Expiration
Date:</B> December&nbsp;15, 2033 <B>See also Section</B><B></B><B>&nbsp;5.1(b).</B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Credit Facility:</B> This Warrant to Purchase Stock
(&#147;<B><U>Warrant</U></B>&#148;) is issued in connection with that certain Loan Agreement, of even date herewith, among XRL 1 LLC, as borrower, the lenders from time to time party thereto and Blue Owl Capital Corporation, as administrative agent
(as may be further amended and/or modified and in effect from time to time, the &#147;<B><U>Loan Agreement</U></B>&#148;; capitalized terms used herein but not defined herein shall have the meaning set forth in the Loan Agreement). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS WARRANT CERTIFIES THAT, for good and valuable consideration, [BLUE OWL CAPITAL CORPORATION] (together with any successor or permitted
assignee or transferee of this Warrant or of any shares issued upon exercise hereof, &#147;<B><U>Holder</U></B>&#148;) is entitled to purchase up to such number of fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> shares (the
&#147;<B><U>Shares</U></B>&#148;) of the above-stated Type/Series of Stock (the &#147;<B><U>Class</U></B>&#148;) of the above-named company (the &#147;<B><U>Company</U></B>&#148;), at the above-stated Warrant Price, all as set forth above and
subject to the provisions and upon the terms and conditions set forth in this Warrant. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SECTION 1. <U>EXERCISE</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1&nbsp;&nbsp;&nbsp;&nbsp;<U>Method of Exercise</U>. Holder may at any time and from time to time exercise this Warrant, in whole or in part,
by delivering to the Company the original of this Warrant together with a duly executed Notice of Exercise in substantially the form attached hereto as Appendix 1 and, unless Holder is exercising this Warrant pursuant to a cashless exercise set
forth in Section&nbsp;1.2, a check, wire transfer of <FONT STYLE="white-space:nowrap">same-day</FONT> funds (to an account designated by the Company), or other form of payment acceptable to the Company for the aggregate Warrant Price for the Shares
being purchased. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2&nbsp;&nbsp;&nbsp;&nbsp;<U>Cashless Exercise</U>. On any exercise of this Warrant, in lieu of payment of the
aggregate Warrant Price in the manner as specified in Section&nbsp;1.1 above, but otherwise in accordance with the requirements of Section&nbsp;1.1, Holder may elect to receive Shares equal to the value of this Warrant, or portion hereof as to which
this Warrant is being exercised. Thereupon, the Company shall issue to the Holder such number of fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> Shares as are computed using the following formula: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">X = <FONT STYLE="white-space:nowrap">Y(A-B)/A</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">where: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">X = the
number of Shares to be issued to the Holder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Y = the number of Shares with respect to which this Warrant is being
exercised (inclusive of the Shares surrendered to the Company in payment of the aggregate Warrant Price); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">A = the Fair
Market Value (as determined pursuant to Section&nbsp;1.3 below) of one Share; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">B = the Warrant Price. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.3&nbsp;&nbsp;&nbsp;&nbsp;<U>Fair Market Value</U>. If shares of the Class&nbsp;are then
traded or quoted on a nationally recognized securities exchange, inter-dealer quotation system or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market (a &#147;<B><U>Trading Market</U></B>&#148;),
the fair market value of a Share shall be the closing price or last sale price of a share of the Class&nbsp;reported for the Business Day immediately before the date on which Holder delivers this Warrant together with its Notice of Exercise to the
Company. If shares of the Class&nbsp;are not then traded in a Trading Market, the Board of Directors of the Company shall determine the fair market value of a Share in its reasonable good faith judgment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.4&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery of Certificate and New Warrant</U>. Within a reasonable time after Holder exercises this Warrant in the
manner set forth in Section&nbsp;1.1 or 1.2 above, the Company shall deliver to Holder a certificate representing the Shares issued to Holder upon such exercise (which certificate may be in the form of an electronic certificate or DTC entry, to the
extent used by the Company at the time of such exercise) and, if this Warrant has not been fully exercised and has not expired, a new warrant of like tenor representing the Shares not so acquired. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.5&nbsp;&nbsp;&nbsp;&nbsp;<U>Replacement of Warrant</U>. On receipt of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form, substance and amount to the Company or, in the case of mutilation, on surrender of this
Warrant to the Company for cancellation, the Company shall, within a reasonable time, execute and deliver to Holder, in lieu of this Warrant, a new warrant of like tenor and amount. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.6&nbsp;&nbsp;&nbsp;&nbsp;<U>Treatment of Warrant Upon Acquisition of Company</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Acquisition</U>. For the purpose of this Warrant, &#147;<B><U>Acquisition</U></B>&#148; means any
transaction or series of related transactions involving: (i)&nbsp;the sale, lease, exclusive license, or other disposition of all or substantially all of the assets of the Company; (ii)&nbsp;any merger or consolidation of the Company into or with
another person or entity (other than a merger or consolidation effected exclusively to change the Company&#146;s domicile), or any other corporate reorganization, in which the stockholders of the Company in their capacity as such immediately prior
to such merger, consolidation or reorganization, own less than a majority of the Company&#146;s (or the surviving or successor entity&#146;s) outstanding voting power immediately after such merger, consolidation or reorganization (or, if such
Company stockholders beneficially own a majority of the outstanding voting power of the surviving or successor entity as of immediately after such merger, consolidation or reorganization, such surviving or successor entity is not the Company); or
(iii)&nbsp;any sale or other transfer by the stockholders of the Company of shares representing at least a majority of the Company&#146;s then-total outstanding combined voting power. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Treatment of Warrant at Acquisition</U>. In the event of an Acquisition in which the
consideration to be received by the Company&#146;s stockholders consists solely of cash, solely of Marketable Securities or a combination of cash and Marketable Securities (a &#147;<B><U>Cash/Public Acquisition</U></B>&#148;), and the fair market
value of one Share as determined in accordance with Section&nbsp;1.3 above would be greater than the Warrant Price in effect on such date immediately prior to such Cash/Public Acquisition, and Holder has not exercised this Warrant pursuant to
Section&nbsp;1.1 above as to all Shares, then this Warrant shall automatically be deemed to be Cashless Exercised pursuant to Section&nbsp;1.2 above as to all Shares effective immediately prior to and contingent upon the consummation of a
Cash/Public Acquisition. In connection with such Cashless Exercise, Holder shall be deemed to have restated each of the representations and warranties in Section&nbsp;4 of the Warrant as of the date thereof and the Company shall promptly notify the
Holder of the number of Shares (or such other securities) issued upon exercise. In the event of a Cash/Public Acquisition where the fair market value of one Share as determined in accordance with Section&nbsp;1.3 above would be less than the Warrant
Price in effect immediately prior to such Cash/Public Acquisition, then this Warrant will expire immediately prior to the consummation of such Cash/Public Acquisition. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Upon the closing of any Acquisition other than a Cash/Public Acquisition, the acquiring, surviving
or successor entity shall assume the obligations of this Warrant, and this Warrant shall thereafter be exercisable for the same securities and/or other property as would have been paid for the Shares issuable upon exercise of the unexercised portion
of this Warrant as if such Shares were outstanding on and as of the closing of such Acquisition, subject to further adjustment from time to time in accordance with the provisions of this Warrant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;As used in this Warrant, &#147;<B><U>Marketable
Securities</U></B>&#148; means securities meeting all of the following requirements: (i)&nbsp;the issuer thereof is then subject to the reporting requirements of Section&nbsp;13 or Section&nbsp;15(d) of the Securities Exchange Act of 1934, as
amended (the &#147;<B><U>Exchange Act</U></B>&#148;), and is then current in its filing of all required reports and other information under the Act and the Exchange Act; (ii)&nbsp;the class and series of shares or other security of the issuer that
would be received by Holder in connection with the Acquisition were Holder to exercise this Warrant on or prior to the closing thereof is then traded in a Trading Market, and (iii)&nbsp;following the closing of such Acquisition, Holder would not be
restricted from publicly <FONT STYLE="white-space:nowrap">re-selling</FONT> all of the issuer&#146;s shares and/or other securities that would be received by Holder in such Acquisition were Holder to exercise this Warrant in full on or prior to the
closing of such Acquisition, except to the extent that any such restriction (x)&nbsp;arises solely under federal or state securities laws, rules or regulations, and (y)&nbsp;does not extend beyond six (6)&nbsp;months from the closing of such
Acquisition. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SECTION 2. <U>ADJUSTMENTS TO THE SHARES</U> <U>AND WARRANT PRICE</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock Dividends, Splits, Etc</U>. If the Company declares or pays a dividend or distribution on the outstanding
shares of the Class&nbsp;payable in additional shares of the Class&nbsp;or other securities or property (other than cash), then upon exercise of this Warrant, for each Share acquired, Holder shall receive, without additional cost to Holder, the
total number and kind of securities and property which Holder would have received had Holder owned the Shares of record as of the date the dividend or distribution occurred. If the Company subdivides the outstanding shares of the Class&nbsp;by
reclassification or otherwise into a greater number of shares, the number of Shares purchasable hereunder shall be proportionately increased and the Warrant Price shall be proportionately decreased. If the outstanding shares of the Class&nbsp;are
combined or consolidated, by reclassification or otherwise, into a lesser number of shares, the Warrant Price shall be proportionately increased and the number of Shares shall be proportionately decreased. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2&nbsp;&nbsp;&nbsp;&nbsp;<U>Reclassification, Exchange, Combinations or Substitution</U>. Upon any event whereby all of the outstanding
shares of the Class&nbsp;are reclassified, exchanged, combined, substituted, or replaced for, into, with or by Company securities of a different class and/or series, then from and after the consummation of such event, this Warrant will be
exercisable for the number, class and series of Company securities that Holder would have received had the Shares been outstanding on and as of the consummation of such event, and subject to further adjustment thereafter from time to time in
accordance with the provisions of this Warrant. The provisions of this Section&nbsp;2.2 shall similarly apply to successive reclassifications, exchanges, combinations, substitutions, replacements or other similar events. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3&nbsp;&nbsp;&nbsp;&nbsp;<U>No </U><U>Fractional </U><U>Share</U>. No fractional Share shall be issuable upon exercise of this Warrant and
the number of Shares to be issued shall be rounded down to the nearest whole Share. If a fractional Share interest arises upon any exercise of the Warrant, the Company shall eliminate such fractional Share interest by paying Holder in cash the
amount computed by multiplying the fractional interest by (i)&nbsp;the fair market value (as determined in accordance with Section&nbsp;1.3 above) of a full Share, less (ii)&nbsp;the then-effective Warrant Price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice/Certificate as to Adjustments</U>. Upon each adjustment of the Warrant Price, Class&nbsp;and/or number of
Shares, the Company, at the Company&#146;s expense, shall notify Holder in writing within a reasonable time setting forth the adjustments to the Warrant Price, Class&nbsp;and/or number of Shares and facts upon which such adjustment is based. The
Company shall, upon written request from Holder, furnish Holder with a certificate of its Chief Financial Officer, including computations of such adjustment and the Warrant Price, Class&nbsp;and number of Shares in effect upon the date of such
adjustment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Treatment as to Adjustments</U>. The Company acknowledges its obligations to file and/or
publicly post (as applicable) an IRS Form 8937 (or similar tax form) if an adjustment (or lack thereof) to the Warrant entitlement results in a distribution under Section&nbsp;305(c) of the Internal Revenue Code of 1986, as amended, and agrees to
notify Holder on a timely basis in the event of such an adjustment (or lack thereof) and, in the case of any required IRS Form 8937 filing, consider, in good faith, any timely received, reasonable written comments of Holder in preparing such IRS
Form 8937. For the avoidance of doubt, if there is more than one permissible method to determine the amount of the constructive dividend for tax purposes, unless Holder gives notice otherwise, the Company agrees to select the method that results in
the lowest constructive dividend amount as long as such method is at a &#147;more likely than not&#148; level of comfort. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SECTION 3. <U>REPRESENTATIONS AND COVENANTS OF THE COMPANY</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations and Warranties</U>. The Company represents and warrants to, and agrees with, the Holder as
follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;All Shares which may be issued upon the exercise of this Warrant shall, upon issuance,
be duly authorized, validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable,</FONT> and free of any liens and encumbrances except for restrictions on transfer provided for herein or under applicable federal and state
securities laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company covenants that it shall at all times cause to be reserved and kept
available out of its authorized and unissued capital stock such number of shares of the Class&nbsp;and other securities as will be sufficient to permit the exercise in full of this Warrant. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;As of the date hereof, each representation and warranty set forth on Schedule 1 hereto is true and
correct. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice of Certain Events</U>. If the Company proposes at any time to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;declare any dividend or distribution upon the outstanding shares of the Class, whether in cash,
property, stock, or other securities and whether or not a regular cash dividend; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;offer for
subscription or sale pro rata to the holders of the outstanding shares of the Class&nbsp;any additional shares of any class or series of the Company&#146;s stock (other than pursuant to contractual <FONT STYLE="white-space:nowrap">pre-emptive</FONT>
rights); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;effect any reclassification, exchange, combination, substitution, reorganization or
recapitalization of the outstanding shares of the Class; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;effect an Acquisition or to
liquidate, dissolve or wind up; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">then, in connection with each such event, the Company shall give Holder notice thereof at the same time
and in the same manner as given to holders of the outstanding shares of the Class. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3&nbsp;&nbsp;&nbsp;&nbsp;<U>Direction to Transfer
Agent</U>. Upon each exercise of the Warrant (in whole or in part), the Company shall promptly deliver irrevocable authorization and direction to its transfer agent to issue book-entry statements representing the Shares. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SECTION 4. <U>REPRESENTATIONS AND WARRANTIES OF THE HOLDER.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Holder represents and warrants to the Company as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase for Own Account</U>. This Warrant and the Shares to be acquired upon exercise of this Warrant by Holder
are being acquired for investment for Holder&#146;s account, not as a nominee or agent, and not with a view to the public resale or distribution within the meaning of the Act. Holder also represents that it has not been formed for the specific
purpose of acquiring this Warrant or the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2&nbsp;&nbsp;&nbsp;&nbsp;<U>Disclosure of Information</U>. Holder is aware of the
Company&#146;s business affairs and financial condition and has received or has had full access to all the information it considers necessary or appropriate to make an informed investment decision with respect to the acquisition of this Warrant and
its underlying securities. Holder further has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the offering of this Warrant and its underlying securities and to obtain additional
information (to the extent the Company possessed such information or could acquire it without unreasonable effort or expense) necessary to verify any information furnished to Holder or to which Holder has access. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3&nbsp;&nbsp;&nbsp;&nbsp;<U>Investment Experience</U>. Holder understands that the
purchase of this Warrant and its underlying securities involves substantial risk. Holder has experience as an investor in securities of companies in the development stage and acknowledges that Holder can bear the economic risk of such Holder&#146;s
investment in this Warrant and its underlying securities and has such knowledge and experience in financial or business matters that Holder is capable of evaluating the merits and risks of its investment in this Warrant and its underlying securities
and/or has a preexisting personal or business relationship with the Company and certain of its officers, directors or controlling persons of a nature and duration that enables Holder to be aware of the character, business acumen and financial
circumstances of such persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.4&nbsp;&nbsp;&nbsp;&nbsp;<U>Accredited Investor Status</U>. Holder is an &#147;accredited investor&#148;
within the meaning of Regulation D promulgated under the Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.5&nbsp;&nbsp;&nbsp;&nbsp;<U>The Act</U>. Holder understands that this
Warrant and the Shares issuable upon exercise hereof have not been registered under the Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of the Holder&#146;s investment
intent as expressed herein. Holder understands that this Warrant and the Shares issued upon any exercise hereof must be held indefinitely unless subsequently registered under the Act and qualified under applicable state securities laws, or unless
exemption from such registration and qualification are otherwise available. Holder is aware of the provisions of Rule 144 promulgated under the Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.6&nbsp;&nbsp;&nbsp;&nbsp;<U>No Shareholder Rights</U>. Without limiting any provision of this Warrant, Holder agrees that as a Holder of
this Warrant it will not have any rights (including, but not limited to, voting rights) as a shareholder of the Company with respect to the Shares issuable hereunder unless and until the exercise of this Warrant and then only with respect to the
Shares issued on such exercise. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SECTION 5. <U>MISCELLANEOUS</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1&nbsp;&nbsp;&nbsp;&nbsp;<U>Term; Automatic Cashless Exercise Upon Expiration</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Term</U>. Subject to the provisions of Section&nbsp;1.6 above, this Warrant is exercisable in
whole or in part at any time and from time to time on or before 6:00 PM, Pacific time, on the Expiration Date and shall be void thereafter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Automatic Cashless Exercise upon Expiration</U>. In the event that, upon the Expiration Date, the
fair market value of one Share as determined in accordance with Section&nbsp;1.3 above is greater than the Warrant Price in effect on such date, then this Warrant shall automatically be deemed on and as of such date to be exercised pursuant to
Section&nbsp;1.2 above as to all Shares for which it shall not previously have been exercised, and the Company shall, within a reasonable time, deliver a certificate representing the Shares issued upon such exercise to Holder (which certificate may
be in the form of an electronic certificate or DTC entry, to the extent used by the Company at the time of such exercise). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2&nbsp;&nbsp;&nbsp;&nbsp;<U>Legends</U>. Each certificate evidencing Shares shall be imprinted with a legend in substantially the following
form: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">THE SHARES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
&#147;<B><U>ACT</U></B>&#148;), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN THAT CERTAIN WARRANT TO PURCHASE STOCK ISSUED BY THE ISSUER TO [BLUE OWL CAPITAL CORPORATION] DATED DECEMBER&nbsp;15, 2023, MAY NOT BE OFFERED, SOLD,
PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance with Securities Laws on Transfer</U>. This Warrant and the Shares issued upon exercise of this
Warrant may not be transferred or assigned in whole or in part except in compliance with applicable federal and state securities laws by the transferor and the transferee (including, without limitation, the delivery of investment representation
letters and legal opinions reasonably satisfactory to the Company, as reasonably requested by the Company). The Company shall not require Holder to provide an opinion of counsel if the transfer is to an affiliate of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Holder, provided that any such transferee is an &#147;accredited investor&#148; as defined in Regulation D promulgated under the Act. Additionally, the Company shall also not require an opinion
of counsel if there is no material question as to the availability of Rule 144 promulgated under the Act. For purposes of an affiliate transfer contemplated herein, the Company hereby approves each and every registered investment company, private
equity fund, venture capital fund, private or similar collective investment vehicle now or hereafter existing that is controlled by one or more affiliated general partners, managing members or investment advisers of, or shares an affiliated
management company or investment adviser with, the Holder as an &#147;affiliate&#148; of the Holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfer Procedure</U>. Subject to the provisions of Section&nbsp;5.3 and upon providing the Company with
written notice, [Blue Owl Capital Corporation] and any subsequent Holder may transfer all or part of this Warrant to any transferee, provided, however, in connection with any such transfer, [Blue Owl Capital Corporation] or any subsequent Holder
will give the Company notice of the portion of the Warrant being transferred with the name, address and taxpayer identification number of the transferee and Holder will surrender this Warrant to the Company for reissuance to the transferee(s) (and
Holder if applicable); and provided further, that any subsequent transferee of this Warrant or of any portion hereof shall agree in writing with the Company to be bound by all of the terms and conditions of this Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.5&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>. All notices and other communications hereunder from the Company to the Holder, or vice versa, shall
be deemed delivered and effective (i)&nbsp;when given personally, (ii)&nbsp;on the third (3rd) Business Day after being mailed by first-class registered or certified mail, postage prepaid, (iii)&nbsp;upon actual receipt if given by electronic mail
and such receipt is confirmed in writing by the recipient, or (iv)&nbsp;on the first Business Day following delivery to a reliable overnight courier service, courier fee prepaid, in any case at such address as may have been furnished to the Company
or Holder, as the case may be, in writing by the Company or such Holder from time to time in accordance with the provisions of this Section&nbsp;5.5. All notices to Holder shall be addressed as follows until the Company receives notice of a change
of address in connection with a transfer or otherwise: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[Holder] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">c/o Blue Owl Capital Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">399 Park Avenue, 37th Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New
York, NY 10022 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Telephone: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Email address: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">with a copy
(which shall not constitute notice) to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cooley LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attn: Michael Tollini </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1299
Pennsylvania Avenue, NW, Suite 700 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Washington, DC 20004-2400 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Email: &nbsp;&nbsp;&nbsp;&nbsp;mtollini@cooley.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice to the Company shall be addressed as follows until Holder receives notice of a change in address: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">XOMA Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attn: Chief
Financial Officer </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2200 Powell Street, Suite 310 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Emeryville, CA 94608 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Telephone:
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Email: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With a copy (which
shall not constitute notice) to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gibson, Dunn&nbsp;&amp; Crutcher LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attn: Ryan Murr and Branden Berns </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">555 Mission Street, Suite #3000 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">San Francisco, CA 94105 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Telephone: (415) <FONT STYLE="white-space:nowrap">393-8373;</FONT> (415) <FONT STYLE="white-space:nowrap">393-4631</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Email: <U>rmurr@gibsondunn.com</U>; <U>bberns@gibsondunn.com</U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.6&nbsp;&nbsp;&nbsp;&nbsp;<U>Waiver</U>. This Warrant and any term hereof may be changed,
waived, discharged or terminated (either generally or in a particular instance and either retroactively or prospectively) only by an instrument in writing signed by the party against which enforcement of such change, waiver, discharge or termination
is sought. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.7&nbsp;&nbsp;&nbsp;&nbsp;<U>Attorneys</U><U>&#146;</U><U> Fees</U>. In the event of any dispute between the parties
concerning the terms and provisions of this Warrant, the party prevailing in such dispute shall be entitled to collect from the other party all costs incurred in such dispute, including reasonable attorneys&#146; fees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.8&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts</U><U>; Facsimile/Electronic Signatures</U>. This Warrant may be executed in counterparts, all of
which together shall constitute one and the same agreement. Any signature page delivered electronically or by facsimile shall be binding to the same extent as an original signature page with regards to any agreement subject to the terms hereof or
any amendment thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.9&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing Law</U>. This Warrant shall be governed by and construed in accordance
with the laws of the State of New York, without giving effect to its principles regarding conflicts of law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.10&nbsp;&nbsp;&nbsp;&nbsp;<U>Headings</U>. The headings in this Warrant are for purposes of reference only and shall not limit or otherwise
affect the meaning of any provision of this Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.11&nbsp;&nbsp;&nbsp;&nbsp;<U>Business Days</U>. &#147;<B><U>Business
Day</U></B>&#148; is any day that is not a Saturday, Sunday or other day on which commercial banks in New York City are authorized or required by Applicable Law to remain closed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Remainder of page left blank intentionally] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature page follows] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties have caused this Warrant to Purchase Stock to be executed by
their duly authorized representatives effective as of the Issue Date written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#147;COMPANY&#148;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>XOMA CORPORATION</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Thomas Burns</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#147;HOLDER&#148;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>[BLUE OWL CAPITAL CORPORATION]</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">APPENDIX 1 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>NOTICE OF EXERCISE </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;The undersigned Holder hereby exercises its right to purchase ___________ shares of the Common/Series ______
Preferred [circle one] Stock of __________________ (the &#147;<B><U>Company</U></B>&#148;) in accordance with the attached Warrant To Purchase Stock, and tenders payment of the aggregate Warrant Price for such shares as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[ ]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;check in the amount of $________ payable to
order of the Company enclosed herewith </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[
]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Wire transfer of immediately available funds to the Company&#146;s account </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[ ]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cashless Exercise pursuant to
Section&nbsp;1.2 of the Warrant </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[ ]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
[Describe] __________________________________________ </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;Please issue a certificate or certificates representing
the Shares in the name specified below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">__________________________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holder&#146;s Name </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">__________________________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">__________________________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(Address) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;By its execution below and for the benefit of the Company, Holder hereby restates each of the representations and
warranties in Section&nbsp;4 of the Warrant to Purchase Stock as of the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">HOLDER: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">_______________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">By:_________________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Name:________________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Title:_________________________________ </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(Date):_______________________________ </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Appendix 1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Schedule 1 </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Representations and Warranties of the Company </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company is a corporation duly organized, validly existing and in good standing under the laws of the state of
Delaware and has all powers and authority, and all licenses, permits, franchises, authorizations, consents and approvals of all Governmental Authorities, required to own its property and conduct its business as now conducted. The Company is duly
qualified to transact business and is in good standing in every jurisdiction in which such qualification or good standing is required by applicable law (except where the failure to be so qualified or in good standing would not result in, and could
not reasonably be expected to have resulted in a Material Adverse Effect). As used herein: (i) &#147;<U>Material Adverse Effect</U>&#148; means (a)&nbsp;an Insolvency Event, (b)&nbsp;a material adverse change in the business, operations, properties,
results of operations or financial condition of the Company, taken as a whole; (c)&nbsp;a material adverse effect on the validity or enforceability of the Transaction Documents taken as a whole or any material provision hereof or thereof; (d)&nbsp;a
material adverse effect on the ability of any Transaction Party to consummate the transactions contemplated by the Transaction Documents, or on the ability of any Transaction Party to perform its obligations under the Transaction Documents to which
it is a party; or (e)&nbsp;a material adverse effect on the rights or remedies of the Holder, the Administrative Agent or the Lenders under any of the Transaction Documents, taken as a whole and (ii) &#147;<U>Transaction Documents</U>&#148; mean the
Loan Documents together with the Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;None of the execution and delivery by the Company of any of the
Transaction Documents to which Parent is party, the performance by the Company of the obligations contemplated hereby or thereby or the consummation of the transactions contemplated hereby or thereby will: (i)&nbsp;contravene, conflict with, result
in a breach, violation, cancellation or termination of, constitute a default (with or without notice or lapse of time, or both) under, require prepayment under, give any Person the right to exercise any remedy (including termination, cancellation or
acceleration) or obtain any additional rights under, or accelerate the maturity or performance of or payment under, in any respect, (A)&nbsp;any Applicable Law or any judgment, order, writ, decree, permit or license of any Governmental Authority to
which the Company or any of its Subsidiaries or any of their respective assets or properties may be subject or bound, (B)&nbsp;any term or provision of any contract, agreement, indenture, lease, license, deed, commitment, obligation or instrument to
which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries or any of their respective assets or properties is bound or committed or (C)&nbsp;any term or provision of any of the organizational documents
of the Company or any of its Subsidiaries, except in the case of clause (A)&nbsp;or (B) where any such event would not result in a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company has all powers and authority to execute and deliver, and perform its obligations under, the Transaction
Documents to which it is party and to consummate the transactions contemplated hereby and thereby. The execution and delivery of each of the Transaction Documents to which the Company is party and the performance by the Company of its obligations
hereunder and thereunder have been duly authorized by the Company. Each of the Transaction Documents to which the Company is party has been duly executed and delivered by the Company. Each of the Transaction Documents to which the Company is party
constitutes the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its respective terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or similar Applicable Laws
affecting creditors&#146; rights generally, general equitable principles and principles of public policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The
execution and delivery by the Company of the Transaction Documents to which the Company is party, the performance by the Company of its obligations hereunder and thereunder and the consummation of any of the transactions contemplated hereunder and
thereunder do not require any consent, approval, license, order, authorization or declaration from, notice to, action or registration by or filing with any Governmental Authority or any other Person, except for the filing of (i)&nbsp;any applicable
notices under securities laws and (ii)&nbsp;those previously obtained and in full force and effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;There is
no action, suit, arbitration proceeding, claim, citation, summons, subpoena, investigation or other proceeding (whether civil, criminal, administrative, regulatory, investigative or informal, and including by or before a Governmental Authority)
pending or, to the knowledge of the Company, threatened in writing (or, in the case of a threat by a Governmental Authority, threatened orally or in writing) by or against the Company or any of its Subsidiaries, at law or in equity, that (i)&nbsp;if
adversely determined, would result in a Material Adverse Effect or (ii)&nbsp;challenges or seeks to prevent or delay the consummation of any of the transactions contemplated by any of the Transaction Documents to which the Company is party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 1.1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Upon consummation of the transactions contemplated by the
Transaction Documents and the application of the proceeds of the Term Loan to be made on the Closing Date, (a)&nbsp;the present fair saleable value of the properties and assets of the Company will be greater than the sum of its debts, liabilities
and other obligations, including contingent liabilities, (b)&nbsp;the present fair saleable value of the properties and assets of the Company will not be less than the amount that would be required to pay its probable liabilities on its existing
debts, liabilities and other obligations, including contingent liabilities, as they become absolute and matured, (c)&nbsp;the Company will be generally able to realize upon its assets and pay its debts, liabilities and other obligations, including
contingent obligations, as they become absolute and matured, (d)&nbsp;the Company will not have unreasonably small capital with which to engage in its business as now conducted, (e)&nbsp;the Company has not incurred, will not incur and does not have
any present plans or intentions to incur debts or other obligations or liabilities beyond its ability to pay such debts or other obligations or liabilities as they become absolute and matured, (f)&nbsp;the Company will not have become subject to any
Insolvency Event and (g)&nbsp;the Company will not have been rendered insolvent within the meaning of any Applicable Law. No step has been taken by the Company or, to its knowledge, any other Person to make the Company subject to an Insolvency
Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;No Default or Event of Default has occurred and is continuing, and no such event will occur upon the
making of the Term Loan to be made on the applicable Credit Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;The Company has timely filed (or caused to
be filed) all Tax returns and reports required by Applicable Law to have been filed by it and has paid all Taxes required to be paid by it (including in its capacity as a withholding agent), except any such Taxes that are being contested in good
faith by appropriate proceedings and for which adequate reserves in accordance with GAAP have been set aside on its books or where any such failure to file or pay would not result, individually or in the aggregate, in a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;None of the Company or any of its Subsidiaries (a)&nbsp;has violated or is in violation of, is under investigation
with respect to or has been threatened to be charged with or been given notice of any violation of, any Applicable Law or any judgment, order, writ, decree, injunction, stipulation, consent order, permit or license granted, issued or entered by any
Governmental Authority or (b)&nbsp;is subject to any judgment, order, writ, decree, injunction, stipulation, consent order, permit or license granted, issued or entered by any Governmental Authority, in each case, that would result in a Material
Adverse Effect. Each of the Company and any Subsidiary of the Company is in compliance with the requirements of all Applicable Laws, a breach of any of which would result in a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Subsidiaries is an &#147;investment company&#148;, or a company
&#147;controlled&#148; by an &#147;investment company&#148;, within the meaning of the Investment Company Act of 1940. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;The Financial Statements are complete and accurate in all material respects, were prepared in conformity with GAAP
applied on a consistent basis during the periods involved (except as may be indicated in the notes thereto) and present fairly in all material respects, in accordance with applicable requirements of GAAP, the consolidated financial position and the
consolidated financial results of the operations of the Company and its Subsidiaries as of the dates and for the periods covered thereby and the consolidated statements of cash flows of the Company and its Subsidiaries for the periods presented
therein. Since December&nbsp;31, 2021, there has been no Material Adverse Effect. The Company and its Subsidiaries have no Indebtedness (or other liabilities) other than (i)&nbsp;identified in the Financial Statements or (ii)&nbsp;incurred by the
Company or its Subsidiaries in the ordinary course of business since December&nbsp;31, 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;Neither the
Company nor any of the directors, officers, employees or, to the Company&#146;s knowledge, agents of the Company have, directly or indirectly, made, offered, promised or authorized any payment or gift of any money or anything of value to or for the
benefit of any &#147;foreign official&#148; (as such term is defined in the FCPA), foreign political party or official thereof or candidate for foreign political office for the purpose of (i)&nbsp;influencing any official act or decision of such
official, party or candidate, including inducing such official, party or candidate to do or omit to do any act in violation of such person&#146;s lawful duty; (ii)&nbsp;inducing such official, party or candidate to use such person&#146;s influence
to affect any act or decision of a foreign governmental authority, or (iii)&nbsp;otherwise securing any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 1.1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
improper advantage, in the case of (i), (ii) and (iii)&nbsp;above in order to assist the Company or any of its affiliates in obtaining or retaining business for or with, or directing business to,
any person. Neither the Company nor any of its directors, officers, employees or, to the Company&#146;s knowledge, agents have made or authorized any bribe, rebate, payoff, influence payment, kickback or other unlawful payment of funds or received
or retained any funds in violation of any law, rule or regulation. Neither the Company nor, to the Company&#146;s knowledge, any of its officers, directors or employees are the subject of any allegation, voluntary disclosure, investigation,
prosecution or other enforcement action related to the FCPA or any other anti-corruption law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;The Company, its
Subsidiaries, their respective directors, officers, employees, and, to the knowledge of the foregoing, agents of the same are and for the past five years have been in compliance with applicable laws and regulations pertaining to export controls and
trade and economic sanctions, including those administered and enforced by the U.S. Department of Commerce, U.S. Department of State, and U.S. Department of the Treasury (collectively, &#147;<U>Trade Control Laws</U>&#148;). None of the Company, its
Subsidiaries, or their respective directors, officers, employees, or, to the Company&#146;s knowledge, the Company&#146;s or it Subsidiaries&#146; agents is: (i)&nbsp;organized under the laws of, ordinarily resident in, or located in a country or
territory that is the subject of comprehensive Sanctions (which as of the date of this Agreement comprise Cuba, Iran, North Korea, Syria, and the Crimea, Donetsk People&#146;s Republic, and Luhansk People&#146;s Republic regions of Ukraine (each a
&#147;<U>Sanctioned Country</U>&#148;)); (ii) 50% or more owned or controlled by the government of a Sanctioned Country; or (iii)&nbsp;(A) designated on a sanctioned parties list administered by the United States or other applicable government
authority, including, without limitation, the U.S. Department of the Treasury&#146;s Office of Foreign Assets Control&#146;s Specially Designated Nationals and Blocked Persons List or Foreign Sanctions Evaders List ( &#147;<U>Listed
Parties</U>&#148;); or (B) 50% or more owned or, where relevant under applicable Trade Control Laws, controlled, individually or in the aggregate, by one or more Listed Parties (collectively, &#147;<U>Sanctioned Parties</U>&#148;). The Company has
obtained all export licenses and other approvals, and timely made all filings, in each case to the extent required pursuant to applicable Trade Control Laws. There are no pending or, to the Company&#146;s knowledge, threatened claims or
investigations against the Company with respect to Trade Control Laws, and no actions, conditions, or circumstances pertaining to the Company&#146;s activities that would reasonably be expected to give rise to any material future claims. The Company
shall not directly or indirectly use the proceeds of this transaction or lend, contribute, or otherwise make available such proceeds to any Sanctioned Country or Sanctioned Party, or in any manner that will result in a violation of Trade Control
Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;The underlying assets of the Company and its Subsidiaries do not constitute Plan Assets. The execution,
delivery and performance of this Agreement and the other Loan Documents do not and will not constitute a <FONT STYLE="white-space:nowrap">non-exempt</FONT> prohibited transaction under Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Internal
Revenue Code, or similar laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp;At no time in the past six years has the Company, its Subsidiaries or any ERISA
Affiliates maintained or contributed to, been required to maintain or contribute to, or otherwise had any liability (contingent or otherwise) with respect to any Employee Benefit Plan subject to Title IV of ERISA, Section&nbsp;302 of ERISA or the
minimum funding requirements of Section&nbsp;412 of the Code, or a &#147;multiemployer plan&#148; (as defined in Section&nbsp;3(37) of ERISA). As used herein, &#147;<U>ERISA Affiliate</U>&#148; means, as applied to any Person, (a)&nbsp;any
corporation which is a member of a controlled group of corporations within the meaning of Section&nbsp;414(b) of the Internal Revenue Code of which that Person is a member; (b)&nbsp;any trade or business (whether or not incorporated) which is a
member of a group of trades or businesses under common control within the meaning of Section&nbsp;414(c) of the Internal Revenue Code of which that Person is a member; and (c)&nbsp;any member of an affiliated service group within the meaning of
Section&nbsp;414(m) or (o)&nbsp;of the Internal Revenue Code of which that Person, any corporation described in clause (a)&nbsp;above or any trade or business described in clause (b)&nbsp;above is a member. Any former ERISA Affiliate of Borrower or
any of its Subsidiaries shall continue to be considered an ERISA Affiliate of Borrower or any such Subsidiary within the meaning of this definition with respect to the period such entity was an ERISA Affiliate of Borrower or such Subsidiary and with
respect to liabilities arising after such period for which Borrower or such Subsidiary could be liable under the Internal Revenue Code or ERISA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p)&nbsp;&nbsp;&nbsp;&nbsp;All written information heretofore or herein supplied by the Company to the Holder, Administrative Agent or any
Lender is accurate and complete in all material respects. There is no fact or circumstance known to the Company that could reasonably be expected to have a Material Adverse Effect that has not been expressly disclosed to the Holder, the
Administrative Agent and each Lender or in required reports and other information filed with the SEC under the Act and the Exchange Act (to the extent publicly available). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 1.1 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>d669381dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g669381g1219031149496.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>XOMA Raises up to $140 Million in <FONT STYLE="white-space:nowrap">Non-Dilutive,</FONT> <FONT
STYLE="white-space:nowrap">Non-Recourse</FONT> Financing </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>from Funds Managed by Blue Owl Capital Backed by VABYSMO<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Royalties </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I><FONT STYLE="white-space:nowrap">Low-cost</FONT> financing
capitalizes on XOMA&#146;s $14</I><I></I><I>&nbsp;million acquisition of VABYSMO</I><SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP><I> (faricimab) royalties in 2021</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Proceeds expected to be used for stock repurchases and additional royalty and milestone acquisitions </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Financing from Blue Owl extends XOMA&#146;s capabilities as a leading provider of capital to emerging biotech companies </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>EMERYVILLE, Calif., December</B><B></B><B>&nbsp;19, 2023 (GLOBE NEWSWIRE) </B>&#150; XOMA Corporation (Nasdaq: XOMA), the biotech royalty aggregator, today
announced it entered into a <FONT STYLE="white-space:nowrap">non-dilutive,</FONT> <FONT STYLE="white-space:nowrap">non-recourse,</FONT> royalty-backed loan for up to $140&nbsp;million of capital with certain funds managed by the credit platform of
Blue Owl Capital Inc. (NYSE: OWL). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The Blue Owl financing provides us with significant <FONT STYLE="white-space:nowrap">non-dilutive</FONT> capital
to drive shareholder value through stock repurchases and additional royalty and milestone acquisitions,&#148; stated Brad Sitko, Chief Investment Officer of XOMA. &#147;This capital infusion comes at an opportune time given the existing state of the
biotech funding market, providing us with an opportunity to accelerate the growth of our royalty and milestones portfolio, which currently consists of two marketed products, two programs in or near registration, five assets in Phase 3 development,
and over 60 assets in earlier stages of development.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Blue Owl&#146;s Life Science efforts are focused on credit, royalty, and equity
investments in innovative healthcare and life sciences companies and products. We recognize the value embedded in XOMA&#146;s differentiated royalty and milestone aggregation business strategy. Our long-established relationship with XOMA&#146;s
management team gives us confidence that they can continue building a balanced portfolio of current and future royalty-generating assets. This financing establishes a long-term partnership with XOMA, as we help broaden their access to capital for
royalty and milestone monetization opportunities,&#148; said Sandip Agarwala, Managing Director at Blue Owl Capital. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Terms of the Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">XOMA has drawn down $130&nbsp;million in principal from Blue Owl and has the option to draw another $10&nbsp;million should the royalties received from VABYSMO<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> (faricimab) sales on or prior to March&nbsp;15, 2026, exceed a predetermined amount. XOMA is obligated to make semi-annual interest payments at a fixed rate of 9.875% per year until the
royalty-backed loan is repaid, at which time VABYSMO<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> royalty payments will revert back to XOMA. The loan is repayable over a <FONT STYLE="white-space:nowrap">15-year</FONT> period, although
XOMA may repay it in full at any time during that period, subject to the terms of the loan. Additionally, XOMA has issued to Blue </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Owl warrants to purchase an aggregate of up to 120,000 shares of XOMA&#146;s common stock in three equal tranches with strike prices of $35.00, $42.50, and $50.00 per share, respectively,
resulting in implied premiums of 122%, 170%, and 217% to the price of XOMA&#146;s common stock at closing, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Advisors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gibson, Dunn&nbsp;&amp; Crutcher LLP served as XOMA&#146;s legal advisor while Blue Owl was advised by Cooley LLP. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About XOMA Corporation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">XOMA is a biotechnology royalty
aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with <FONT STYLE="white-space:nowrap">pre-commercial</FONT> and commercial
therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires the future economics, the seller receives <FONT STYLE="white-space:nowrap">non-dilutive,</FONT>
<FONT STYLE="white-space:nowrap">non-recourse</FONT> funding they can use to advance their internal drug candidate(s) or for general corporate purposes. The Company has an extensive and growing portfolio with more than 70 assets (asset defined as
the right to receive potential future economics associated with the advancement of an underlying therapeutic candidate). For more information about the Company and its portfolio, please visit <U>www.xoma.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Blue Owl Capital Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Blue Owl (NYSE: OWL) is a
leading asset manager that is redefining alternatives. With $157&nbsp;billion in assets under management<SUP STYLE="font-size:75%; vertical-align:top">1</SUP>, we invest across three multi-strategy platforms: Credit, GP Strategic Capital, and Real
Estate. Anchored by a strong permanent capital base, we provide businesses with private capital solutions to drive long-term growth and offer institutional and individual investors differentiated alternative investment opportunities that aim to
deliver strong performance, risk-adjusted returns, and capital preservation. Together with over 650 experienced professionals in more than 10 offices globally, Blue Owl brings the vision and discipline to create the exceptional. To learn more, visit
<U>www.blueowl.com</U>. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of September&nbsp;30, 2023 </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements/Explanatory Notes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain
statements contained in this press release are forward-looking statements within the meaning of Section&nbsp;27A of the Securities Act of 1933 and Section&nbsp;21E of the Securities Exchange Act of 1934, including statements regarding XOMA driving
shareholder value through stock repurchases and royalty acquisitions; the timing and amount of potential commercial payments to XOMA and other developments related to VABYSMO<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> (faricimab); the
anticipated timings of regulatory filings and approvals related to assets in XOMA&#146;s portfolio; and the ability of XOMA to continue building a balanced portfolio of current and future royalty generating assets. In some cases, you can identify
such forward-looking statements by terminology such as &#147;anticipate,&#148; &#147;intend,&#148; &#147;believe,&#148; &#147;estimate,&#148; &#147;plan,&#148; &#147;seek,&#148; &#147;project,&#148; &#147;expect,&#148; &#147;may,&#148;
&#147;will&#148;, &#147;would,&#148; &#147;could&#148; or &#147;should,&#148; the negative of these terms or similar expressions. These forward-looking statements are not a guarantee of&nbsp;XOMA&#146;s&nbsp;performance, and you should not place
undue reliance on such statements. These statements are based on assumptions that may not prove accurate, and actual results could differ materially from those anticipated due to certain risks inherent in the biotechnology industry, including those
related to the fact that our product candidates subject to <FONT STYLE="white-space:nowrap">out-license</FONT> agreements are still being developed, and our licensees may require substantial funds to continue development which may not be available;
we do not know whether there will be, or will continue to be, a </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
viable market for the products in which we have an ownership or royalty interest; if the therapeutic product candidates to which we have a royalty interest do not receive regulatory approval, our
third-party licensees will not be able to market them; and the impact to the global economy as a result of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic.&nbsp;Other potential risks to XOMA meeting these expectations are described in
more detail in XOMA&#146;s most recent filing on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> and in other filings with the Securities and Exchange Commission.&nbsp;Consider such risks carefully when considering XOMA&#146;s prospects.&nbsp;Any
forward-looking statement in this press release represents XOMA&#146;s beliefs and assumptions only as of the date of this press release and should not be relied upon as representing its views as of any subsequent date.&nbsp;XOMA disclaims any
obligation to update any forward-looking statement, except as required by applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EXPLANATORY NOTE: Any references to &#147;portfolio&#148; in
this press release refer strictly to milestone and/or royalty rights associated with a basket of drug products in development.&nbsp;Any references to XOMA&#146;s &#147;assets&#148; in this press release refer strictly to milestone and/or royalty
rights associated with individual drug products in development. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the date of this press release, all assets in XOMA&#146;s milestone and royalty
portfolio, except VABYSMO<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> (faricimab) and IXINITY<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> [coagulation factor IX (recombinant)], are investigational compounds. Efficacy and
safety have not been established. There is no guarantee that any of the investigational compounds will become commercially available. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"># #
# </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Investor contact:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Media contact:</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Juliane Snowden</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kathy Vincent</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">XOMA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KV Consulting&nbsp;&amp; Management</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">+1-646-438-9754</FONT></FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">+1-310-403-8951</FONT></FONT></FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">juliane.snowden@xoma.com</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">kathy@kathyvincent.com</P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>xoma-20231215.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 12/19/2023 11:33:28 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:xoma="http://www.xoma.com/20231215"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.xoma.com/20231215"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" namespace="http://fasb.org/us-gaap/2023" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" namespace="http://fasb.org/us-types/2023" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="xoma-20231215_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="xoma-20231215_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="xoma-20231215_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="xoma_DocumentAndEntityInformationTable" name="DocumentAndEntityInformationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="xoma_DocumentAndEntityInformationLineItems" name="DocumentAndEntityInformationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>xoma-20231215_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 12/19/2023 11:33:32 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="xoma-20231215.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="xoma-20231215.xsd#xoma_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="xoma_DocumentAndEntityInformationTable" />
    <link:loc xlink:href="xoma-20231215.xsd#xoma_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="xoma_DocumentAndEntityInformationLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember" xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="xoma_DocumentAndEntityInformationTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="xoma_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="25" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="26" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="28.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="30.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="31.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="37.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="38.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="39.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="40.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="41.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="42.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="43.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="44.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="45.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="46.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="47.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="48.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="49.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="50.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="51.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="52.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="53.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="54.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="55.001" priority="2" use="optional" />
  </link:definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>xoma-20231215_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 12/19/2023 11:33:28 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="xoma-20231215.xsd#xoma_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="xoma_DocumentAndEntityInformationTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="xoma_DocumentAndEntityInformationTable" xlink:to="xoma_DocumentAndEntityInformationTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="xoma_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="xoma_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Table]</link:label>
    <link:loc xlink:href="xoma-20231215.xsd#xoma_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="xoma_DocumentAndEntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="xoma_DocumentAndEntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="xoma_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="xoma_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Series A Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A Preferred Stock [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember" xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Series B Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B Preferred Stock [Member]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>xoma-20231215_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 12/19/2023 11:33:29 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="xoma-20231215.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="xoma-20231215.xsd#xoma_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="xoma_DocumentAndEntityInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="xoma_DocumentAndEntityInformationTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="xoma-20231215.xsd#xoma_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="xoma_DocumentAndEntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationTable" xlink:to="xoma_DocumentAndEntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember" xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="48.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="49.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="50.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="51.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="52.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="53.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="54.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="55.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g669381g1219031149496.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g669381g1219031149496.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !T .<# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
*HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140199061201168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 15, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_xoma_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">XOMA Corp<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000791908<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 15,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-2154066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2200 Powell Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Emeryville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(510)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">204-7200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_xoma_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.0075 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">XOMA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_xoma_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">8.625% Series A Cumulative Perpetual Preferred Stock, par value $0.05 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">XOMAP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_xoma_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Depositary Shares (each representing 1/1000th interest in a share of 8.375% Series B Cumulative Perpetual Preferred Stock, par value $0.05 per share)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">XOMAO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_xoma_DocumentAndEntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">xoma_DocumentAndEntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>xoma_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>d669381d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="xoma-20231215.xsd" xlink:type="simple"/>
    <context id="duration_2023-12-15_to_2023-12-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
        </entity>
        <period>
            <startDate>2023-12-15</startDate>
            <endDate>2023-12-15</endDate>
        </period>
    </context>
    <context id="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-15</startDate>
            <endDate>2023-12-15</endDate>
        </period>
    </context>
    <context id="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-15</startDate>
            <endDate>2023-12-15</endDate>
        </period>
    </context>
    <context id="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-15</startDate>
            <endDate>2023-12-15</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2023-12-15_to_2023-12-15"
      id="Hidden_dei_EntityRegistrantName">XOMA Corp</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="duration_2023-12-15_to_2023-12-15"
      id="Hidden_dei_EntityIncorporationStateCountryCode">DE</dei:EntityIncorporationStateCountryCode>
    <dei:AmendmentFlag contextRef="duration_2023-12-15_to_2023-12-15">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-12-15_to_2023-12-15"
      id="Hidden_dei_EntityCentralIndexKey">0000791908</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-12-15_to_2023-12-15">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-12-15_to_2023-12-15">2023-12-15</dei:DocumentPeriodEndDate>
    <dei:EntityFileNumber contextRef="duration_2023-12-15_to_2023-12-15">001-39801</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-12-15_to_2023-12-15">52-2154066</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-12-15_to_2023-12-15">2200 Powell Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2023-12-15_to_2023-12-15">Suite 310</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-12-15_to_2023-12-15">Emeryville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-12-15_to_2023-12-15">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-12-15_to_2023-12-15">94608</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-12-15_to_2023-12-15">(510)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-12-15_to_2023-12-15">204-7200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-12-15_to_2023-12-15">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-12-15_to_2023-12-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-12-15_to_2023-12-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-12-15_to_2023-12-15">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">Common Stock, $0.0075 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">XOMA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember">8.625% Series A Cumulative Perpetual Preferred Stock, par value $0.05 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember">XOMAP</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember">Depositary Shares (each representing 1/1000th interest in a share of 8.375% Series B Cumulative Perpetual Preferred Stock, par value $0.05 per share)</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember">XOMAO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-12-15_to_2023-12-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-12-15_to_2023-12-15">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M4(2'!LY>@T.([M@CN4R@T\1<Q)N:V\_GD>R&QR'M=H)>#R/<"0!Z".$X2<
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MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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M%S?W1:[-XPFNWPQP>'3^ 5!+ P04    "  0/9-799!YDAD!  #/ P  $P
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MKP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ $#V35YE<G",0!@
MG"<  !,              ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    "  0/9-7H(XGPF8%  "\&0  &               @($."   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ $#V35Y^@&_"Q @
MX@P   T              ( !J@T  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M"  0/9-7EXJ[',     3 @  "P              @ &&$   7W)E;',O+G)E
M;'-02P$"% ,4    "  0/9-7'#AEZC\!   \ @  #P              @ %O
M$0  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ $#V35R0>FZ*M    ^ $
M !H              ( !VQ(  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
M4$L! A0#%     @ $#V35V60>9(9 0  SP,  !,              ( !P!,
J %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  "A4

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d669381d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="d669381d8k.htm">d669381d8k.htm</File>
    <File>xoma-20231215.xsd</File>
    <File>xoma-20231215_def.xml</File>
    <File>xoma-20231215_lab.xml</File>
    <File>xoma-20231215_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d669381d8k.htm": {
   "nsprefix": "xoma",
   "nsuri": "http://www.xoma.com/20231215",
   "dts": {
    "inline": {
     "local": [
      "d669381d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "xoma-20231215.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "xoma-20231215_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "xoma-20231215_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "xoma-20231215_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 3,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 4,
   "entityCount": 1,
   "segmentCount": 3,
   "elementCount": 31,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 29
   },
   "report": {
    "R1": {
     "role": "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2023-12-15_to_2023-12-15",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d669381d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2023-12-15_to_2023-12-15",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d669381d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeriesBPreferredStockMember",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B Preferred Stock [Member]",
        "terseLabel": "Series B Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "xoma_DocumentAndEntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.xoma.com/20231215",
     "localname": "DocumentAndEntityInformationLineItems",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Line Items]",
        "terseLabel": "Document And Entity Information [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "xoma_DocumentAndEntityInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.xoma.com/20231215",
     "localname": "DocumentAndEntityInformationTable",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Table]",
        "terseLabel": "Document And Entity Information [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeriesAPreferredStockMember",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.xoma.com//20231215/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001193125-23-298155-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-298155-xbrl.zip
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M])H@XL4?;0N_&-@B8 2"6*A<VU>_9PDV_S)"O7!^'RCJ6?%'T*M!> GB<Y'
M%KV9/$M@M9:,C9[$R\;K5#+8V0Y;?VIE72))1^%K.US*VT$O],ROK:DMXQ%M
M;SQ&C0#??Q+CO@CV@&F-+C%$R/1G"]:;^HYMVJ&"@UDV/%9>EP:VN70[!Q?1
MD-Q^SBL+IT\PG<#QS^2 'JPK9.N.)#80UO?#"T_L[(TKUN**#]\M5RS<V7?
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M6?_C(F*D[G;:E[,/RSE\-= :9'.>J@' #>XB)G'X2O['UQ_L[&V-MG?H2?=
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M9["G-E_EA9[C<V\5!+=> ,I%]A"6^Y"T1#1_26(8P3'GK6^%);-O"!M#J<B
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MY:X#&#X@!XMW3";09"/X>]""OY=Z$0/C-3I5"5W!S"0C;%&PFSV"!8RU0UY
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MUO('_5L:%5RS^#'Y^0H3NYA&L6'@ !S9P$3VQ)H)\[TH06\CRZXE^0EQ";A
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M74LR80Z\,F?'5<DZ8D.CQ.'V=P^VQM8_>8*<%%GJ)4K?)<)@HMD[^>-3;BG
MSDE66RB!,:>P<IE"*74?Z1 CQ&$>Y28QT08/&0]OV613LB6>B'5AEH')?L[
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MU*S:E88-FS=+_V/_*ZU+5LN-;SUY/9O][M.>MZZ<I]?MQ)H]@O@6X'WH?EN
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M>)"K+!RF4987#SF]WA-J&&!F?P-\P*L#*@/'Q $J'HXF@=\UD -:G%IO)MH
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M?4DO\,?1"/&SX=>_;$'2T^]AO:_KFFQ+-GX?H@MK34( N1MU-K=9Y-QARG3
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M7$\BGF'N9AAAV6NUGWJE*_A_(A+5>R2U-_VIE#'>-[Y\>X"<8QRIV_GM6.-
MF1$PPCK_6_?/!B:QKMO&1:R1F?)@AK#:HLC[6![0P',GW1!:4X]J.E^BNUT#
M1VW+_%R[U6I&VQ=M_1-/Y0N3[[YHJ>5.GF@&;'Q)?R'H_866NM7C:H;M34R_
M7,<)#E>D)W*X##,&B("Y9Z#,@ACI1$^CHJ(>!!6]$\<G$L.@KA-R;5:?JXF9
M?6:P)O*0D@QY4I4@]?">B\UYX^\V/EB1/6E?I<[N6Y+#QM=WN'K^YR=4<L7\
MZ5?)WI<_/S2W,'J^?=M"_[*)(+T%MO&./HJWXKL3Z*MY8KP9I9_K@?FB%1S>
M,A:Z:B\;C_Z]2O:6ML-^HS=,EE-CKYZ1DF%D:J(_AMGV99*A>K,TI29YG$3K
M^E;Y^9UY8=J]'>N8&Z:;"1DT4"Z],;WM)/L&YX_21_@UCL8X.R</9$ O_#'%
M8J"KB+XL#9S+ \H\M8/.N--5&'/3+'@8)[2B-RB,L84TO2S"Y]C,/1P;=)-(
MGBD/0[4]7Y;8U[_P)T3EU+E*?L.DO@I0$8S=CNM;CQX"=":$\"3W% 1E7H<F
M]NNE)A]_++,HG_#L:6YK&)D)B>6&]:"151Z1EW(2O2:'<!!J2]HAWE#O,FHZ
M$D8Q)N%QDE2>>BWWN7JB_/@;&H3$#=+R98Q5$(% "W[H=O@7VW60\JZPDH(A
M04E;?*-D"JNWIG-:;X)=9;3J4]+5]H[JY=P!EQN;/<<F,L:'^.[5FMN0+4@V
M*&; YLI20YBHDX1&8";C%4\)#I3M#!TJV\$ME >ZFF-2>>7H H488G!/\ 7Q
M"0>,XKX(\]PU",2F26)5U;D(/^B$^]A3"\L7RLY';5B;:^J,#R%*I>9RF:DS
M\=K-X15#P4!JCY?2+!2<%%=YI^E<95_GLH9M'CLGKJ=36)\92AIBN[36!7JK
MP>?[J[F@"@N>:YLOYW/J;V>Z2(4R>[W4YTZ*;!JWQ-.+[_Y2."9JT4P3:D8@
MV>30'%=; SD9S87SU)B34J4(S8K=TG<]-YEU0%G$Z&)T L3TUJ%^@)-YE,C,
M"J >&O%IAO*=BL-;AF,D[0=>QS*B7&R^Y BK\<X*67%7\],T+,-$*CJLVWYC
M*>8M#=_/J(_@U(QT$!.7Q@R9!DO5CD53#[#=3CM"(&II[LA/&"$YJXQF%-2H
M/YW*C3SDJW5U'*TLX=D_';UXW&0]T=0?@WW>GKO&7#Q6&K@B-8[BP@II;LA\
M#<?( -J@_CF&+Z^C-):NMF/<5QQ;>>15KE&31:^V)\26G2&*C2W"DC2S=1^F
MW4,&<FHA_7]YY$"F #&NMAG)K=SFEE8<YY%?9I$,$;F@UF*.QO!X;&-A;O$$
M]+;R^O7ZBZ[MJ-O!L7NQL/1MXC$R9[ \[5L(6I:#W-3<QTQMCOGNPJA]G&#.
M6MF-/%YFB8"LZEE)5BLU$,;]QW(RFTM[,7H&9BACY_LQ-SPD=8I S"J6P>U&
M)6E%#GVIUBIW\!+$1:XY6(YR$#XASS/W>5"4F;5S G6NF=<YF6EJQDSE%)TT
M=1/=.O3V2D6A?*.K8:$F9BF/0@]<%5:@F&> 1A,H<FD'9K,(!]1KL<HC*@1,
MENQ8V;&UG9^\=2<$I/#LFP(.WL;]"M-,]E.POK9U=!? &:;CC4B'@Y\8;D9=
MSNZV\L#KKVV[P&&;W!@S\QW.XM(.MT7MM"TUN1RT0:5<KQ=NH,BK95"]K_NW
M&3?"@,9+F94BLH8UYU8E)*B*<S"IZE(G<A+'3$*]LSYE>@0G$R,;V*99(QUQ
M%J'GS[U%'/I85%[AK6*Q HYNQ[6IM&OECZYA8;6@H_Q4&4'Q!2O',W8OLA4E
M'H"^_DNI%EH$*+=:I'[P8J#3NTU%J\_.*O:%M0M0Z9/*]-+;ZID7E"WB&!$5
MM 9^F:MG6V*]7+9<%.,5<F!C9J&P]IE,@.V;PP(.9SGW.T67I5EN"AFIR).Z
M?Z>9*:$6$6M+_ /; 9J:5-,SO&I1KABW'[$*CD=N+U+X[VH#JNFDC9G0S+J[
MZ:2?B4UW44BKC&@MX1E"KNJBWA+;^8Y]#,61S>=)M0/[RCAY NO@\<2ZZ#HE
MOQ#-4M<@A<2YQ0,7$].<+% "-;*]O(F K"-/N7. [?^\1C\R8I&L'M8YK3PT
MH3)Y%$##JMJD-%J,)Y<)=2SES5<'3Q@+C>^%5^?:GXW$BJCP()POBU/(B=2]
M%KP;0'/=AN;4-A\W+L> 7 45U3 ;1>8D%MB$7/,L#3C'"(YO; =I(+:1 P:X
MT2+521A(;W9/FY,.#O8QV*2*#=1Q=(VM@,=9A"I_C+VS?1,;N18-$TBS5>FY
MUS)8A$@G#@3DQH)@U)'Q:>$:G-GN=B@X@"B1V7E/;F!PS2UT10.^S' 3:3>R
ME;)]X&M<H5Q+3K\U;R\]+_5;I,B3MV4731*B30F$U\9LAJ 'DZ8%2!]OB_71
M%-@ZJW+P5C?O+!#][PZZ'S=-MA8KEL+K9,;J<Z[UAYR'E$B3$60 <;CZ? 8U
M6MWJ46GGM7_=,>TNT++S/8CU=1GC="UCI"&6G^;68=F]SBEEQ+,(&_^1PA:M
MPQ&G42IRZ'$<8!Y.M'%3'L5ICER'!QI:ASH_AH)AB@8<YF',^J4=<2AO,E8K
MCQ!D<[8ZGU6ZBE3'&>;+N>$X$SU"%R;V/4?'KAE:+GS>TU?\9CP(+?@_KM&[
MT7/\?_5=R(@JRI&TVY!L6^*(S.Y&NA2 6H0K$X :<;#&K1;/@3-R.!#7[=1!
MH3X;$MR^'?TPXQ2;[8Q >3=F*OFKD$5;$[CQT&R[+<D>Q@!0#/3 <T!H3CW#
MB[1QV>EG[($L(;.)TB5WV\1DW2;L!.)EX@_7FE-G(FEB3LJ@Z5T$YM0LY.!0
M:W0P<-$ _Z57(7<F,>VD K<,^HIU_Y2;X-+*N'V0052@_D3FVD@+#Y)$?"\!
MUBE OB)/GC\'[Y%>I:C"X,E(L$10D7M;W?E!=P/_]%;PR_V^B8G#!JIQ.]:)
M9W=X'(UK1[6:]"=^2F%FA!;U-CEE0W1'G:4@@O3"V?T<0*G-- A,HR*KR04U
MTP OF</MI5M+6_4"E-T.[70#BONL)72BCL5[#^??-ZW<S'<(HW0L_=$DP,WT
MNB0E'K\"C=]W_.%IT2UV@"Z&$C_(@=PFESSWPQ%Y"4A";0!D5W?V#V)$(\9Q
M)=AV;@N=M]+ )*4I*O3]-GD1A^%';$N(]=H$N4SC=)O\EGY#WN@.,QHE*FSJ
M!4X ,0_7>4G^C#3_RC=X<1'A<, %PS%U0*+8(1 0#EJGK!#DQMO6[K6^77X'
MS_+)M$QL(>4EE]@_)A;0;&1@K&9(V2*C"6?.:LMMXBGS7CC_?R]Y<"\..N&,
MT:KGZJ=>[\*#!<@>6'?$F$/\.DT_$!.K^*.]7 B$GP1E:@YJ"C* #3E9>A94
MX1<:!7\Z'W9TIXCH'4(55O]#C.(HH*2*T%'8N""%_B+CU2A9Y](43GR+E'^3
M>2S6F:B,F*;9IXD8TE4\E,?K$0_++;_[L\-D4?+',C%^B2):+&V@DYU0YJYZ
M.&V&X6Z4=3+1E/(Q"N,4)EFVWI5D55)L]EF2@!M<\%I' MKY-,^90FR>8MMD
MQW<[50+P?>)VM+4T@;7HMJI>$>5-<UPYK9QX&=L]DOI5\2H'-GKM>0"8J=S9
M [$)ROUC/>5*^UH?1,DM,4HSFK ^[Y'S.SAL;;XS8Z;=*$;) N%FN+<]JEG1
MPH\G[AZS\MZ8U(F]9T]V-P'F#ZU"W'4>H=:58E_C%$Q$1BVZ;HBZ# HGQ"'
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MP1%4Z%09K*P:':9A1H;9,2AVXR+-W(HEI<GR.74K\.%=> P@^1SP$'5[\N+
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MTG*O.AF#/I7AEG(3XYB29\7&,G+R.YLL2;+5)U*U)6UQX%\LSIU^86,<Y%+
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MT].+>[^<7E$DS]5;@$H(MNV0$K*B^T;.O<?/GG4[%SI)\E5\'291:(GV['T
M9D@$]_/#[NY][^M]F&/Z38$>O.,C]7AW=_?)P\=/9"/W3D//U3KE;U[PQ?W7
MF#!I!]2\SXF]?AF3D]*LLJ5P%Q%L*U?62E]IX^H8R'T>[)?SM[V:)+M'+&02
MI0Y3W4ZMQ=1][^;Q8TP/ +,9X[@%6%B%(=#]O4W0!2C&UV"X8J>LGGKVY.GN
MCYL3K6VQFF_)%NY97+UW(E4BX=3;]$\E4G^*1CFQ[64B=L(_P_GBA3K*EL48
M+>'-"=O+59BHM\N, TF'8#; :NH0K+G\WG=T<'  PC^GM+XR-?]M?W<#<FX
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MA=4W4[>PVP+--YJF5'GM(J_DDWIU9L:=+ORDCTS3A 9T@J  <DGVMAJF%&4
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M/CQVW_PLB,9'<TAH?EA>X,>GYG/XGTOO5>8,'AU$U#KG.35T5Y]XALKFX!H
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M-C2GOOEX<+D&Y"JHJ(;9*#(WL< NY)J':< ]1G!]8SM) [&-'## C1:I3L)
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MSD"6D#E$Z2=W.\1DW2'L".)EXD_7FE-K(NEB3LJ@:5X$YM0LY.!0:W0P<-$
M_Z57(;<F,?VD K<-^HAU_Y2[X-+.N'^0052@_D0&VT@/#Y)$_"P!UBE OB)/
MGC\'[Y%>I:C"X,U(L$10D9M;W7FANX%_>BOXY7G?Q,1I ]6X'>O$LSLL1_/:
M4:TF_8E7*<R0T*+>)Z=LB.ZHLQ1$D%XXNY\#*+6A!H'I5&0UN:!F&N!/YO!X
MZ='24;T 9;=#)]V XCYK"9VH8_'>P_WW32\W\QG"*!U+@S0)<#.]+DF)QX]
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MQNDPEHN[#]OX%(S)W+Y"91.$ S(/AMO1X%/_N-'>+6]JL),*M=>TJ7# [KU
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MV-?3K;2&)Z^M47*_\/CX.+!7'TWU\(EZM%UE<Q0L+VI32;K2#O6>QW892DA
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M,4 =>\O+0(P'G=+LY/@AU):*-(KP/FO,(-@>[DIA7-)%*=BLA<N]4RN:(3C
M#\9(#(- &$CR?ZYH3'KUQD$KT.@H5%EB>P+M1Z!4%!?_7/]=\0)D);B)L<[!
M.;.A0?\ +V[0[]NBWW]UZ/=-T>^[0+__<NB/'YDS])%L&*-?Z041_9%X></'
M[#$^"/SU]-> O<:.#OKG,#3DMR4= 2_+ .,@"^'"CFV@"G4S%XB8JVLY-_R6
MLP<:^S4O299IO ;@RXSIJ-^*14-?J^N(_^RBG$"GJ(8[!$ZL5$U"#3^(XW#+
MDM0+_Z7S^M?G]0JO813TIG2#L!&)-@8:54=#D%4"40KSFKL[&U4#8.S%\AY
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M<IGUL^&MWW]YM0([@#NN,N5IREDFZ1+2"8A&2(O&STZTHI/RRL@MR2-'28Y
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M,S@Q9#AK+FAT;5!+ 0(4 Q0    ( ! ]DU=O/!1%;CT  #\7 0 0
M      "  4T8  !D-C8Y,S@Q9&5X-#$N:'1M4$L! A0#%     @ $#V35](+
MEWIM/0  0!<! !               ( !Z54  &0V-CDS.#%D97@T,BYH=&U0
M2P$"% ,4    "  0/9-7B!7?)6H]  ! %P$ $               @ &$DP
M9#8V.3,X,61E>#0S+FAT;5!+ 0(4 Q0    ( ! ]DU<8:@8],1(  !U!   1
M              "  1S1  !D-C8Y,S@Q9&5X.3DQ+FAT;5!+ 0(4 Q0    (
M ! ]DU<2> X-W@,  $L/   1              "  7SC  !X;VUA+3(P,C,Q
M,C$U+GAS9%!+ 0(4 Q0    ( ! ]DU=?R^<?VP4  &LW   5
M  "  8GG  !X;VUA+3(P,C,Q,C$U7V1E9BYX;6Q02P$"% ,4    "  0/9-7
M);?^FOL'  !27   %0              @ &7[0  >&]M82TR,#(S,3(Q-5]L
M86(N>&UL4$L! A0#%     @ $#V35P=,O-..!0  =CL  !4
M ( !Q?4  'AO;6$M,C R,S$R,35?<')E+GAM;%!+!08     "0 ) #T"  "&
%^P     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
